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ABSTRACT
The ability of pyridoxal 5’-phosphate (PLP)-dependent 2,2-dialkylglycine 
decarboxylase (DGD) to catalyze decarboxylation and transamination of amino acids at 
a single active site depends on the subsite within the active site that cleaves a-H  and a - 
COCT bonds. As observed in the crystal structure, the strategic position of glutamine 52 
at the active site suggests a role in enhancing decarboxylation via formation o f a 
hydrogen bond to the substrate carboxyl group. Supporting evidence for this hypothesis 
is provided by studies with glutamine 52 active site mutants, computer modeling and 
protein sequence analyses.
Ten mutant DGDs containing alanine, asparagine, aspartate, arginine, 
glutamate, glycine, histidine, leucine, lysine, and tryptophan at position 52 were 
produced. All, except the histidine mutant, exhibited decreased rates of decarboxylation 
compared to wild-type. Histidine and asparagine mutants showed measurable 
decarboxylation rates. These results and that o f  wild-type DGD suggest that hydrogen 
bonding with the substrate is required for decarboxylation. Mutants incapable of 
hydrogen bonding to the substrate, such as alanine, leucine and tryptophan mutants, 
showed negligible decarboxylation reactions.
Transamination rates increased for some mutants and decreased for others. 
These data imply that the DGD subsite is influenced by the presence of glutamine 52.
iii
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Furthermore, there is evidence showing that the subsite environment o f wild-type 
DGD, the histidine and the glutamate mutants are different; the three DGD forms 
exhibited different chromophores at around /.max of 500 nm when treated with 2- 
methylalanine or L-alanine in the presence o f 3% glycerol. These results have 
important implications for other PLP-dependent enzymes, such as ornithine 
aminotransferase and y-aminobutyrate aminotransferase. Since protein sequence 
alignment indicates DGD is homologous to the two aminotransferases, mutations at 
amino acid position corresponding to glutamine 52 o f DGD at the active sites of these 
aminotransferases could disrupt the functionality o f the enzymes.
Protein sequence alignment showed that all but one o f the PLP-dependent 
aminotransferases lack residues at position 52 capable o f hydrogen bonding with the 
substrate carboxyl group, further re-affirming the role of glutamine 52 in 
decarboxylation.
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1Chapter 1 
Literature review
1.1. Discovery of vitamin B6
The early 1930s marked the beginning o f  a series of notable events that unraveled 
the mystery of vitamin B6'. The early work was reviewed by Snell (1986), Leklem (1991) 
and Snell (1994). In 1932, a compound with the formula Q H nO jN  was first isolated in 
rice polishings. Two years later, Gyorgy discovered the compound could prevent rat 
pellagra and named the factor vitamin B6 to distinguish it from vitamin B3, B4 and B5. The 
first successful isolation of pure crystalline vitamin B5 was reported in 1938 (Snell,
1994). One year later, the crystal was identified as 3-hydroxy-4, 5-dihydroxymethyl-2- 
methylpyridine and was chemically synthesized (Snell, 1994). The pyridine derivative 
was eventually named pyridoxine, a terminology introduced by Gyorgy in 1939. Other 
major forms of vitamin B6were identified in studies involving microorganisms (Leklem, 
1991; Snell, 1994). Snell and coworkers found that pyridoxal and pyridoxamine, but not 
pyridoxine, supported and enhanced microbial growth (Snell et al., 1942). These findings 
led to chemical synthesis of the two newly discovered pyridoxine derivatives in 1944
1 Recommended as the generic name for all 3-hydroxy-2-methylpyridine derivatives (IUPAC-IUB 
Commission on Biochemical Nomenclature, 1973)
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->
[Snell (1944) and Harris et al. (1944) cited in Leklem (1991)]. The availability of the 
three forms o f vitamin B6 paved the way for further research into the properties of the 
vitamin (Figure 1).
pyridoxine (PN) pyridoxal (PL) pyridoxamine (PM)
Figure I. Structures o f  pyridoxine, pyridoxal and pyridoxamine.
During his initial investigations into Streptococcus faecalis  tyrosine 
decarboxylase conducted in 1940, Gale concluded that enzyme production was dependent 
on substrate and a factor in the growth media, which was later identified as pyridoxine 
[Gale (1946) cited in Snell (1994)]. This was the first clue o f an enzyme related to 
vitamin B6. Studies with a crude preparation o f S. faecalis tyrosine decarboxylase 
provided evidence that phosphorylated or ‘activated’ pyridoxal was required for enzyme 
functionality (Gunsalus et al., 1944). Coupled with improved chemical synthesis of 
phosphorylated pyridoxal, Gunsalus and colleagues also concluded that the coenzyme is a 
monophospho-pyridoxal. In 1945, Gale and Baddiley showed that pyridoxal phosphate 
activates arginine, lysine, ornithine and tyrosine apodecarboxylases (Snell, 1986). 
Attention was then shifted to explaining the possible role o f pyridoxal phosphate in
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
biological reactions. In that same year, Snell demonstrated reversible non-enzymatic 
transamination between pyridoxal and amino acids (Snell, 1986). He suggested that 
amino transfer between pyridoxal and pyridoxamine may be possible in enzymatic 
reactions. In other words, the cofactor was envisioned as an amino carrier between keto 
acids. This hypothesis was supported by a series of experiments involving partially 
purified enzymes such as aspartate aminotransferase, glutamate-oxaloacetic transaminase, 
tyrosine decarboxylase and glutamate-aspartate transaminase (Snell, 1986).
Although Gunsalus and coworkers demonstrated the requirement o f 
phosphorylated pyridoxal for enzyme activity, they were unable to determine the position 
o f phosphorylation in pyridoxal. In theory, phosphorylation could take place at the 3- 
hydroxyl, hemiacetal hydroxyl or 5-hydroxymethyl position. It was not until 1961 that 
the position o f the phosphate moiety at the 5’-hydroxymethyl group o f pyridoxal was 
finally confirmed by two separate research groups (Snell, 1994).
1.2. PLP-catalyzed reactions at a-carbon
The requirement for pyridoxal 5’-phosphate (PLP) in amino acid decarboxylation 
and transamination is well established from studies with Streptococcus faecalis and 
Lactobacillus casei that date back some fifty years ago. Since the early studies described 
above, enzymes other than aminotransferases and decarboxylases requiring PLP to 
function have been discovered. Although not an exhaustive list, these enzymes are
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
involved in deamination, racemization and transsulfuration of amino acids and in the 
metabolism of fats and carbohydrates (Dolphin et al., 1986). However, half of more than 
100 PLP-dependent enzymatic reactions so far discovered are transamination type 
reactions (Sauberlich, 1985).
Reactions catalyzed by coenzyme PLP-requiring enzymes are categorized into 
three groups: The reaction could take place at a-, (3- or y-carbon. Decarboxylation, 
transamination and retroaldol cleavage require bond breaking at the a-carbon. Figure 2 
depicts the general scheme o f the three PLP-catalyzed reactions. The first step o f all three 
reactions entails the internal Schiff base formation between PLP and e-NH, of the lysine 
side chain. This is followed by substrate displacement o f the e-amino group of the lysine 
residue to form an external Schiff base or aldimine with the co factor. Depending on the 
orientation of the substrate-PLP complex at the active site, one of the three bonds can be 
broken: Ca-COO in decarboxylation, Ca-H in transamination and Ca-R in retroaldol 
cleavage. A number of requisites have to be fulfilled for bond cleavage to take place.
One criterion for effective enzyme catalysis requires the coplanarity between the 
imine and n system. Dunathan (1966) proposed that the bond to be broken has to be 
oriented perpendicular to the plane o f  the pyridine ring and the imine double bond to 
maximize orbital overlap between the Ca-R bond and the conjugated n electron system 
(Figure 3). Once the C0-R bond is broken, the electrons can be delocalized into the 
extended n system to stabilize the intermediate. In addition, the stability of the 
intermediate is enhanced by the protonated pyridinium nitrogen.
4
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One of these three bonds can be broken
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Figure 2. PLP-catalyzed decarboxylation, transamination and retrol cleavage (Gani, 1991).
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6it electron withdrawal
Figure 3. External aldimine Ca-R bond to be broken is parallel to tt molecular orbital 
or perpendicular to ring.
In free solution, PLP complexed with an amine can catalyze the bond breaking 
process at a relatively slow rate when supplemented by metal cations such as Cu2\  Zn: ' 
and Al3* (Leussing, 1986). Because free rotation around the Ca-N bond can occur in 
solution, any of the three substituents on the a-carbon can be the leaving group. Hence 
chemical model reactions are inherently non-selective with several potential reaction 
courses and products. In biological systems, however, the enzyme active site geometry is 
rigidly defined. Only metabolically compatible amino acids are transformed at a 
substantial rate. The active site confers reaction specificity by bonding the PLP-substrate 
complex and orienting the substrate appropriately. By aligning a specific Ca-R bond of 
the substrate perpendicular to the cofactor ring, the enzyme can dictate the outcome of the 
reaction. Unlike chemical PLP reactions, metal cations are not involved in enzyme- 
catalyzed reactions.
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In aminotransferases and decarboxylases, the PLP-substrate complex orientation 
can be accomplished by three attachment points at the enzyme active site. Aspartate 
aminotransferase from E. coli complexed with the inhibitor, 2-methyI-L-aspartate, 
(Okamoto et al., 1994) provides an example o f how the complex is oriented at the active 
site. The first two attachment sites are common in PLP enzymes; protonated pyridinium 
nitrogen is held in place by negatively charged aspartate and the phosphate moiety lies in 
a polar pocket. The substrate binding site provides the third unique mold for maintaining 
a desired Ca-N conformation; side chains Arg292 and Arg386 form salt bridges with 
substrate a -  and co-carboxyl groups, respectively. The three-point attachment system 
orients the methyl group o f 2-methyl-L-aspartate, which corresponds to the substrate a- 
proton, perpendicular to the ring. Two o f the three attachment points at the active site of 
the ornithine decarboxylase from Lactobacillus 30a are similar to those of 
aminotransferases (Hackert et al., 1994; Momany et al., 1995). Likewise, Asp316 ion 
pairs with the N1 pyridinium ring of the cofactor and the PLP phosphate group lies in a 
site lined with polar residues. The third domain accountable for substrate specificity is 
tentatively assigned to Glu235, which lies within hydrogen bonding distance o f the 5- 
amino group of L-omithine.
Ivanov and Karpeisky (1969) proposed on thereotical grounds that PLP reorients 
during transimination. They postulated that transformation from internal to external 
Schiff base results in the exposure of opposite faces. The key stereochemical principle is 
that the reaction occurs on one face of the planar enzyme bound PLP-substrate complex;
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
the reactive face is exposed to solvent and accessible to substrate and external reagents 
whereas the opposite face remains shielded by protein. Two potential modes, rotation at 
C-5 to C-5’ and rotation at C-4 to C-4’, are shown in Figure 4.
8
(A)
rotation about the axis
H -N
Re attack
h3c  o h N-Lys
R
Si attack
Figure 4. PLP reorientation during transimination: (A) C-5 to C-5’ rotation and (B) C-4 to C-4' rotation.
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Both transformations result in the exposed face si face relative to 4 ’-C in the PLP- 
substrate complex and re face in internal Schiff base. The exposed si face is prone to 
solvent attack while the re face is protected by the protein. Support for the postulate came 
from stereochemical studies with sodium borohydride reduction o f internal and external 
Schiff base of PLP enzymes (Palcic and Floss, 1986 and references therein). Hydride 
attack took place at the re face o f PLP-substrate complex in aspartate aminotransferase, 
tyrosine decarboxylase, tryptophan synthase, tryptophanase and tyrosine phenol-lyase. By 
contrast, PLP-substrate, PLP-product, or PLP-inhibitor complexes of PLP enzymes 
studied so far showed protonation at the si face. These enzymes include aspartate and 
alanine aminotransferases, tyrosine decarboxylase and tryptophan synthase.
The X-ray structure o f aspartate aminotransferase reveals the re face o f internal 
Schiff base is partially exposed to solvent, whereas the si face is shielded by the enzyme 
(Ford et al., 1980). Upon inhibitor methylaspartate binding, the PLP ring rotates 30° with 
C-5 to C-5’ as a hinge. The motion is accompanied by the exposure of the si face to the 
solvent environment, where bond breaking and forming take place. On the contrary, the 
re face is protonated in D-amino acid aminotransferase (Sugio et al., 1995).
The next logical question to ask is why the ancestral enzyme selected one face o f 
the co factor and not the other to undergo catalysis? A theory was put forward by 
Dunathan and Voet (1974). They reasoned that the choice between re and si face is an 
early and completely random occurrence; neither choice is more efficient. The choice, 
once made, is difficult to reverse. Inversion o f the PLP face requires a complete
9
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rearrangement of active site residues and is energetically unfavorable. The progenitor 
protein, with its fixed cofactor binding, may have low substrate specificity. Through the 
course o f  evolution, the protein evolved into more sophisticated enzymes with the 
preservation of the original choice of PLP binding.
However, Christen et al. (1996) presented evidence that the preservation of the si 
face in L-amino acid aminotransferases (and re face in D-amino acid aminotransferases), 
which faces the catalytic base of the protein, is not coincidental. Model calculation of the 
L-amino acid/PLP complex showed that (1) the external aldimine must have the COO' 
positioned far away from the phosphate group to attain conformation of minimum energy 
for maximum binding and (2) the Ca-H bond has to be positioned to undergo chemical 
reaction perpendicular to the Ti-system and towards the protein. To fulfill two such 
requirements, the si face of the 4’-C o f the cofactor will be facing the protein and 
therefore towards the residue that catalyzes protonation. Meanwhile, the re side will be 
exposed to the solvent.
1.3. Properties of pyridoxine derivatives
Vitamin B6is a water-soluble vitamin. The three forms, pyridoxine, pyridoxal and 
pyridoxamine, are light sensitive in solution (Ang, 1979). The three forms are heat stable 
in acidic medium and heat labile in alkaline solution (Leklem, 1991).
The characteristic electron withdrawing property o f the pyridine ring accounts for 
the diverse reactions PLP catalyzes (Leklem, 1991). Leussing (1986) listed several
10
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structural features of PLP that makes the cofactor an ideal candidate for forming Schiff 
base and catalyzing enzymatic reactions. These include the 2-methyl group that brings the 
pKL, o f the nitrogen ring proton closer to biological range; the phenoxide oxygen that 
stabilizes the immonium Schiff base, facilitates expulsion o f nucleophiles at the 4 ’-C 
position and acts as a proton transfer intermediary; the phosphate moiety which anchors 
the coenzyme in a polar pocket; and the protonated N which neutralizes the negative 
charge acquired by imine as amino acid groups are activated and regulates the pKLa of the 
3-hydroxyl group.
PLP dependent enzymes exhibit characteristic absorption peaks in the 300 to 500 
nm region that arise from vitamin B6-containing chromophore. These spectra tend to 
represent mixture of PLP and its related derivatives at the enzyme active site. Each 
species o f the mixture can be described quantitatively by a lognormal distribution curve 
of uniquely specified position, height, width and skewness (Metzler and Metzler, 1987). 
Since width and skewness values are constant for similar compounds, it is possible to 
resolve overlapping spectral bands in complex equilibrium mixtures. Based on 
calculations from PLP spectra of aspartate aminotransferase and glutamate 
decarboxylase, Metzler and Metzler (1987) were able to determine the parameters 
describing distribution curves o f potential pyridine derivatives at the active site.
Figure 5 depicts some PLP derivatives present at the active site. An absorption 
band with of about 430 nm is characteristic o f a nitrogen-protonated Schiff base of 
the PLP. This ketoenamine form is covalently bound to the active site lysine. The
11
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unprotonated Schiff-base linkage with an undissociated phenolic hydroxyl group absorbs 
at about 330 nm and is often called the enolimine form. These two absorption peaks 
represent tautomeric forms o f PLP. PMP absorbs at approximately 325 nm. The spectrum 
of ketimine peaks at 327 nm and the shape o f the absorption band is similar to that of 
PMP. A quinonoid intermediate, observed in some PLP enzymes reacted with 
quasisubstrates, exhibits an absorption peak at approximately 490 to 500 nm.
12
ketoenamine enolimine pyridoxamine quinonoid ketimine
5'-phosphate intermediate
(PMP)
Figure 5. Different PLP forms present at enzyme active site have characteristic absorption peaks.
1.4. Burkholderia cepacia 2,2-dialkylglycine decarboxylase (DGD)
1.4.1. Introduction
2,2-dialkylglycine decarboxylase (DGD; EC 4.1.1.64) from the soil bacterium, 
Burkholderia (Pseudomonas) cepacia, was first reported by Aaslestad and Larson (1964). 
DGD is an unusual PLP-dependent enzyme because it catalyzes two distinct reactions, 
decarboxylation and transamination, at one active site. The decarboxylation-dependent
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transamination reaction proceeds via a ping pong bi-bi mechanism. This double 
replacement mechanism proceeds as follows: the enzyme reacts with one substrate to give 
a covalently modified enzyme and releases one product, and then reacts with the second 
substrate to form a second product and regenerate the enzyme. Phosphoglycerate mutase, 
a phosphate-transferring enzyme, is one such example. The enzyme is phosphorylated by 
one substrate to form a phosphorylenzyme, which then transfers the phosphoryl group to 
a second substrate.
The two half reactions catalyzed by DGD are depicted in Figure 6. Reaction (1) 
involves PLP reacting irreversibly with either 2 methylalanine (2MA) or isovaline to 
produce carbon dioxide and ketone coupled with amino transfer to the cofactor to give 
PMP. Reaction (2) entails the amino transfer from PMP to pyruvate to yield L-alanine 
and regenerate PLP; this second step is reversible. The combined reaction of (1) and (2) is 
equivalent to the non-enzymatic reaction put forward by Kalyankar and Snell (1962).
The exact biological role of DGD remains unclear. Dempsey (1969) and Esaki et 
al. (1994) demonstrated that DGD is widespread in many soil bacterial and fungal 
species, implying that this enzyme probably plays an important ecological or 
physiological role within the soil community. DGD provides a soil dwelling 
microorganism defense against fungal dialkylglycine containing peptides, which are 
cytotoxic. The major constituents o f these cytotoxic peptides are 2-methylalanine and 
isovaline (Bruckner and Pryzbylski, 1984). Both dialkylamino acids are substrates of
13
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DGD. Keller et al. (1990) postulated that DGD may be involved in the degradation of 
fungal peptides to provide supplemental carbon and nitrogen sources for the hosts.
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where R = H tor 2MA and R = CH, tor isovaline.
Figure 6. DGD decarboxylation-dependent transamination reaction.
Purified to homogeneity, DGD was first studied in some detail by several research 
labs (Bailey and Dempsey, 1967; Aaslestad et al., 1968; Lamartiniere et al., 1971). Based 
on experiments involving radioactive substrates and predicted stoichiometry of the 
reaction, Bailey and Dempsey (1967) demonstrated that DGD catalyzes a sequential 
decarboxylation and transamination reaction. The DGD subunit was shown to be 45 kDa 
by SDS gel electrophoresis and 47 kDa by sedimentation centrifugation in urea
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(Lamartiniere et al., 1971). Since the native enzyme is estimated at 180 kDa 
(Lamartiniere et al., 1971; Sato et al., 1978), DGD is thus a tetrameric enzyme consisting 
of four identical subunits. Keller et al. (1990) reported the cloning, sequencing and 
expression of DGD in E. coli. The gene sequence encodes a subunit of 434 amino acids 
with the carboxyl end sharing substantial sequence similarity with aminotransferases but 
not decarboxylases. DGD can thus be best described as an aminotransferase, which 
through evolution has acquired decarboxylation activity, and not a decarboxylase that has 
evolved the ability to transaminate. The recombinant DGD expression in E. coli 
facilitates production of highly purified enzyme. Crystallization o f the purified enzyme 
leads to the identification o f the 3D protein structure. The 3D structure o f DGD was 
eventually solved by Toney et al. (1995a), who provided intimate structural analysis of 
the enzyme and related how catalytic mechanisms could be achieved through precise 
organization within the enzyme.
1.4.2. Structural organization of DGD
The three dimensional structure of DGD was determined to 2.1 A resolution by 
Toney et al. (1995a). The following is an account o f the overall structural organization of 
the enzyme. In brief, a DGD monomer interacts tightly with another monomer to form a 
dimer. This is followed by a dimer associating loosely with another dimer to form a 
functional tetramer.
15
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A DGD monomer is composed of 434 amino acids with a calculated molecular 
mass o f 46,544 Da (Keller et al., 1990). Figure 7 depicts a ribbon presentation of the 
folded structure o f the monomer. The secondary structural elements in the DGD subunit 
are presented in Figure 8. A DGD subunit is divided into three domains: a large PLP 
binding domain, a smaller C-terminal domain and an N-terminal segment. The large PLP 
binding domain is made up o f seven-stranded P-sheet (a, g , f  e, d, b, c) o f which six of 
the strands are parallel (+, +, +, +, +, +). This sheet is covered on both sides by eight
helices of various lengths. Structures of all PLP-dependent enzymes discovered so far 
have the unique topology of the seven-stranded P-sheet at the large domain (Isupov et al., 
1998). The interaction between the small domain with the large domain is mediated by 
the four-stranded antiparallel p-sheet (D, E, F and G). The three a-helices of the small 
domain pack against the p-sheets on the side opposite that o f the large domain. The PLP 
binding site is located near the N-terminus o f helix 4 and the C-termini o f strands e and f .  
The monomer also contains two binding sites for alkaline metal ions. One is located near 
the active site and accounts for the dependence o f activity on potassium ion. The other 
site binds sodium ion and is located at the carboxyl terminus o f a a-helix.
Two monomers associate tightly to form the dimeric structure. The interaction 
surface between the monomers is large. There is 3770 A ' o f  a monomer surface area 
buried upon dimer formation. Close contacts between the two monomers in the dimer are 
made by the N-terminal helix and its associated loop. This substructure participates in
16
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Figure 7. Stereoscopic presentation o f a DGD monomer, a-helices and 3-sheets are drawn as coils and 
arrows, respectively. The large PLP binding domain is at the bottom, the C-termmal domain is at the upper 
right. The N- and C-termim are marked (diagram from Toney et al.. 1995a).
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Figure S. Secondary structural elements o f  a DGD monomer. Rectangular boxes in bold and thin 
outline represent a-heiices above and below the 3-sheets, respecnvely. 3-strands are represented 
by boxes with arrows, which give the direction o f the strands from amino to carboxy end. The 
residue range o f  each secondary structure is indicated. The approximate 1C* and N a‘ binding sites 
are shown (diagram from Toney et al.. 1995a).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
numerous hydrophobic and ionic interactions with the large domain of the other 
monomer.
The tetrameric structure has an overall dimension of 100 x 85 x 60 A and is 
formed by the symmetric association o f two dimers. The dimer-dimer interface is three 
times smaller than that of the monomer-monomer. This dimer-dimer interface is largely 
formed by the interactions between helix 6 and its N-terminal associated loop with their 
symmetry mates, and between this helix and strand c of the large domain (3-sheet. About 
ten residues from each subunit are involved in the formation o f  the tetramer interface. 
Several hydrogen bonds and a water-mediated salt bridge also contribute to the interface.
Toney et al. (1995a) noted that the DGD monomer is similar in structure and 
overall folding to aspartate aminotransferase (AAT) monomer. The seven stranded 
pleated sheets and helices correspond closely in both monomers. Also, the shape and 
dimensions of DGD dimer are similar to AAT dimer. The DGD active site, however, is 
only moderately homologous to that o f AAT. The only similarity is that the positions of 
the PLP pyridine nitrogen atom, the aspartate carboxylate group and the imidazole 
nitrogen atom of histidine are conserved in both AAT and DGD. Another notable feature 
is the tryptophan position in front o f the PLP ring. The amino acid is parallel with the 
ring in AAT but perpendicular in DGD.
Four active sites are present in a DGD tetramer, which explain the four PLP 
binding sites per molecule o f enzyme reported by Sato et al. (1978). Each active site is
19
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formed from residues contributed by both monomers in the dimer formation. The DGD 
active site will be discussed in more detail in the next two sections.
1.4.3. Substrate and reaction specificity of DGD
DGD acts on various dialkyl-a-amino acids (Honma et al., 1972). The ability of 
DGD to decarboxylate or transaminate certain substrates depends on substrate orientation 
at the active site (Figure 9). The DGD active site consisting o f three binding sites 
proposed by Toney et al. (1995a) is also included in Figure 9 to aid in explaining the 
results described below.
Bailey et al. (1970) proposed that the amino acid side chain, not the scissile bond, 
directs substrate-PLP conformation at the active site. They observed that DGD 
decarboxylates 2-methylalanine and L-alanine but transaminates D-alanine; hence they 
concluded that site-specific binding of the alkyl side chain at a common subsite anchors 
the substrate in such a way that permits decarboxylation or deprotonation at the scissile 
bond. Similarly, site-specific binding of an alkyl group could also explain why DGD 
metabolizes a-methyl-L-serine but not a-methyl-D-serine (Honma and Shimomura,
1976). The above observations indicated that site III can accommodate an alkyl group, 
but not a carboxyl group of D-ala or a carbinol group of a-methyl-D-serine.
In addition, the higher decarboxylation rate o f  L-isovaline compared to D- 
isovaline (Aaslestad et al., 1968; Honma et al., 1972) suggests that the a-methyl group
20
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Figure 9. Position o f  various substrates at DGD active site. Amino side chain o f  substrates 
points away and perpendicular to paper. Dotted line represents plane o f  PLP ring in imine 
complex.
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fits better at site III to permit efficient catalysis. The larger ethyl group o f D-isovaline 
cannot be accommodated as well as a methyl group in site III, thus resulting in less 
effective decarboxylation. Inhibition study with D- and L-cycloserine further supports the 
concept that amino acid side chain, in particular a methyl group, orients substrate 
conformation (Bailey et al., 1970; Figures 9 and 10). The ring methylene positions the a- 
hydrogen of L-cycloserine for deprotonation. Such cleavage would result in a more stable 
inhibitor-cofactor complex, thus enhancing inhibition. However, the ring carbonyl would 
be directed towards scission in the D-isomer. Inhibition is less effective since the 
complex undergoes rearrangement and hydrolysis.
H
pyr pyr
L-cycloserine
H
pyr pyr
D-cycloserine
Figure 10. DGD inhibition by L- and D-cycloserine. pyr = pyridine.
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In the proposed model by Toney et al. (1990a) (Figure 9), two o f the three binding 
sites can accommodate a COO' group. Gln52 and Lys272 are located at the first site while 
second site is occupied by Arg246. These residues could potentially form hydrogen bonds 
with the substrate COO' groups. Supporting evidence for the three distinct binding sites 
comes from alternative substrates studies by Sun et al. (1998) [an example is a-methyl-a- 
aminomalonate in Figure 9]. They demonstrated that (a) site I accommodates the scissile 
bond from either a carboxylate or a hydrogen, (b) site II accepts an alkyl or a carboxylate 
group, and (c) site III accepts a methyl group but not a carboxylate or large alkyl group. 
The last inference agrees with the findings discussed in the previous paragraphs. In short, 
the dual nature of the binding sites is important in the ability o f DGD to carry out 
decarboxylation and transamination.
1.4.4. Normal versus abortive decarboxylation
When the substrate enters the active site of PLP-dependent enzyme, 
transimination reaction between cofactor and amino terminal of amino acid results in 
external Schiff base formation. The imine is anchored at the active site by ionic and 
hydrogen bonding interactions with residues around the catalytic site. Breaking of the Ca- 
COO bond results in the formation o f a carbanionic intermediate. This intermediate 
structure is stabilized by the conjugated n -electrons o f the pyridine ring and also by its 
electron withdrawing capability. Decarboxylation reactions in all PLP decarboxylases are 
similar up to this point.
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Protonation at Ca o f the carbanionic intermediate allows most decarboxylases to 
form amine and PLP-lysine Schiff base. However, the carbanion o f the DGD-catalyzed 
reaction follows a different route. Protonation at 4’-C permits DGD to generate a ketone 
and PMP. PMP then reacts with another keto acid in the second half reaction to form 
amino acid and regenerate PLP. One explanation for such selectivity may be related to 
the position of the general acid (Figure 11).
H - normal r , _ l . r ,
'l decarboxylation 1 i 2
R1\L-R2
h 2*
4 H NHI
I JN
H-.0 PLP f  amino product
abortive 
decarboxylation HiO PMP -  ketone
Figure 11. Regioselectivity o f  protonation o f  quinonoid intermediate leads to normal 
and abortive decarboxylation.
If the position o f general acid is closer to Ca, normal decarboxylation occurs. If 
the general acid is located near the 4 ’-C, abortive decarboxylation takes place. Studies
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with mono and dicarboxylic amino acids suggest that the presence or absence o f a 
carboxylate group at site II could determine protonation at either Ca or 4’-C (Sun et al., 
1998). Ionic interaction between Arg406 and substrate COO' minimizes cofactor tilting 
so that either Ca or 4’-C is physically assessible to protonation by Lys272. Conversely, 
substrates lacking such ionic interaction would result in a larger cofactor tilt angle thus 
excluding protonation at Ca. The absence o f carboxylate groups at site II leads in 
protonation at 4’-C in 2MA and D-ala (Figure 9). L-ala and a-methyl-a-aminomalonate 
can undergo protonation at Ca and 4 ’-C because of the ionic interaction between Arg406 
and carboxylate group.
PLP-dependent decarboxylases catalyze protonation at 4 ’-C at a rate o f once in 
103 turnover (Tramonti et al., 1998 and references therein). It has been proposed that a 
histidine protonates at Ca whereas a lysine residue protonates at 4 ’-C in methionine and 
glutamate decarboxylases [Akhtar et al. (1990) and Tilley et al. (1994) cited in Tramonti 
et al. (1998)]. The absence of such a histidine in the active site vicinity may have 
determined the fate of DGD protonation at 4 ’-C position and not at Ca. A detailed 
analysis o f the histidines, if any, at the DGD active site will provide clues if  such theory 
is valid.
The protonation step of abortive decarboxylation is similar to the protonation step 
o f transamination. In other words, DGD decarboxylation process is essentially a 
transamination with the exception that the leaving group is a-COO'. During 
transamination, protonation takes place via the intramolecular 1,3-prototropic shift, which
25
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involves the transfer of substrate a-H  to 4’-C of the cofactor. Work done on some PLP 
enzymes suggests that the intramolecular proton shifting step could be mediated by a 
single base group at the active site in a suprafacial process (Palcic and Floss, 1986). 
Lysine may be the possible candidate for the role after it is released from the internal 
aldimine. The suprafacial process requires the general base to be located on the si face of 
the substrate-PLP complex for decarboxylation and protonation to be carried out.
Ultimately, protonation position of the quinonoid intermediate determines the 
course o f reaction: protonation at Ca leads to normal (nonoxidative) decarboxylation 
while protonation at 4 ’-C results in abortive (oxidative) decarboxylation. Site directed 
mutagenesis of aminotransferases involving replacing active site lysine with other 
residues drastically reduced catalytic activities, thus supporting the role of lysine as a 
catalytic base (Toney and Kirsch, 1989; Nishimura et al., 1991). However, the active site 
lysine of aromatic L-amino acid decarboxylase may not function as a proton donor in the 
reprotonation step (Nishino et al., 1997).
1.5. Significance of conducting DGD research
DGD is structurally closely related to two medically important aminotransferases: 
ornithine aminotransferase (OmAT) and y-aminobutyrate aminotransferase (GabaAT) 
(Shen et al., 1998; Toney et al., 1995b). Gyrate atrophy, a hereditary disease that leads to 
progressive blindness and eventually blindness in humans, arises from dysfunctional 
OmAT (Shen et al., 1998 and references therein). In mammals, GabaAT regulates y-
26
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aminobutyrate (GABA) concentration in the brain, where the molecule is a major 
inhibitory neurotransmitter (Toney et al., 1995b and references therein). The enzyme is 
also the target enzyme of an anti-epileptic drug, 4-aminohex-5-enoate, which is known as 
vinyl-GABA or Vigabatrin [Mumford and Cannon (1994) cited in Toney et al. (1995)].
So far, only the 3D structure of OmAT has been published (Shen et al., 1998).
The structure of GabaAT is still under X-ray crystallographic investigation but not yet 
available (Toney et al., 1995b). The significant sequence homology between DGD and 
GabaAT allowed the active site o f GabaAT to be modeled from that of DGD (Toney et 
al., 1995b). From the computer-modeled GabaAT active site, Toney and coworkers were 
able to demonstrate how vinyl-GABA inactivates the enzyme. Shen et al. (1998) and 
Toney et al. (1995b) also noted that OmAT and GabaAT share many similar features 
with DGD at the active site. The knowledge gained from understanding the mechanism of 
action of DGD can be applied to elucidate how OmAT and GabaAT active sites function.
1.6. Project objectives
PLP-dependent aminotransferases are divided into four subgroups based on their 
degree of similarities in primary structure (Mehta et al., 1993). Protein sequence 
alignment showed that DGD is closely related to subgroup II (Mehta and Christen, 1994). 
However, DGD possesses the ability to catalyze decarboxylation not found among the 
subgroup II members. Furthermore, DGD catalyzes both decarboxylation and 
transamination reactions o f amino acids at one active site. The sequential cleavage at a-
27
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carboxyl and a-hydrogen at the active site is intriguing. Which amino acid(s) is(are) 
responsible for the unique ability of DGD to carry out decarboxylation in addition to 
transamination?
There are three main objectives in this thesis project:
(i) to determine which amino acid at the DGD active site enables the enzyme to 
catalyze decarboxylation in addition to transamination and how the amino acid 
promotes decarboxylation;
(ii) to determine if  this amino acid influence the transamination ability of DGD;
(iii) to apply the knowledge o f DGD active site to OmAT and GabaAT active sites to 
elucidate how they function.
1.7. Hypothesis testing on how DGD catalyzes decarboxylation
Toney et al. (1995a) postulated that DGD-catalyzed decarboxylation may involve 
Gln52 and Tyr301\ These two amino acids reside at the top o f the substrate binding site 
and have no similar counterparts in AAT. Toney and co-authors presented the following 
model for the role o f Gln52 in decarboxylation. During protein crystallization, a MES 
molecule occupies the position where a substrate normally resides at the active site.
Gln52 is within hydrogen bonding distance with the MES sulfonate group. It is therefore 
logical to hypothesize that Gln52 could be a hydrogen bond donor to the carboxylate 
group of a substrate in place of MES molecule. The onset o f hydrogen bonding to
* denotes amino acid o f  the other monomer.
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substrate carboxylate group is most likely required to orient the scissile bond 
perpendicular to the pyridine ring o f PLP for promoting decarboxylation. The resulted 
quinonoid intermediate is then protonated at the 4 ’-C position. Subsequent 
transamination involves Lys272 serving as a proton acceptor and donor.
Current literature does not mention whether the decarboxylation and 
transamination reactions are separate events catalyzed by Gln52 and Lys272 respectively 
or are dependent on both residues for effective catalysis. However, in my opinion, the 
concept of decarboxylation and transamination as separate events catalyzed by Gln52 and 
Lys272 respectively is a much simpler model to visualize: Removal o f Gln52 will abolish 
decarboxylation activity; removal o f  Lys272 will eliminate transamination activity.
The following hypothesis is formulated based on the above description at the 
DGD active site: Removal of Gln52 and hence the amide group will abolish 
decarboxylation activity but will not affect the transamination reaction. Replacement of 
Gln52 with amino acids capable o f hydrogen bonding to substrate carboxylate group will 
retain decarboxylation activity. Alternatively, replacement of Gln52 with amino acids 
incapable o f functioning as hydrogen bond donors will exhibit low or undetectable 
decarboxylation activity.
Several alternatives have been explored to test the above hypothesis. Plasmid 
DNAs encoding WT DGD were initially subjected to site-directed mutagenesis to mutate 
the codon coding for Gln52 into any other amino acids. Mutated plasmid DNA was then 
transformed into E. coli. Host bacteria carrying mutated plasmid DNA were induced to
29
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express the recombinant protein. DGD mutant proteins were eventually purified by 
conventional chromatography methods and tested for the ability to decarboxylate 2- 
methylalanine and transaminate L-alanine separately. In addition, computerized protein 
sequence alignment has categorized DGD as a member of the PLP-enzyme family (Mehta 
and Christen, 1994). Sequence alignment o f DGD with gene sequences o f members from 
this enzyme family may help explain how Gln52 functions. Furthermore, 3D structures of 
some PLP-enzymes, in particular aminotransferases, have been solved and could provide 
additional information on how decarboxylation could be catalyzed at DGD active site.
1.8. Dissertation outline
This dissertation is divided into 5 parts. This chapter introduces the general 
concept o f  vitamin B6and the types o f reactions catalyzed by PLP. Current literature 
relevant to DGD is also discussed in this chapter. Chapter 2 deals with the construction of 
Q52X DGD mutants, experiments conducted on the mutant enzymes and discussion on 
the experimental results. Chapter 3 describes comparative sequence alignment o f DGD 
with moderately to highly homologous protein sequences downloaded from protein 
databanks on the World Wide Web. Amino acid alignment o f Gln52 and certain histidine 
residues in DGD with similar proteins may yield clues on how DGD carries out 
decarboxylation. Active site comparisons o f 3D structures of known PLP enzymes such 
as AAT, OmAT and DGD are also discussed. Chapter 4 documents DGD purification
30
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and spectrophotometric studies on WT and K272A DGDs. Lastly, in Chapter 5 are 
recommendations for the future direction o f the project.
31
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Chapter 2 
Wild-type and mutant 2,2-dialkylglycine decarboxylases: 
Role of active site Gln52 investigated by site directed mutagenesis
2.1. Abstract
The ability o f Burkholderia (Pseudomonas) cepacia 2,2-dialkylglycine 
decarboxylase (DGD) to catalyze sequential decarboxylation and transamination at a 
single active site depends on the dual nature of the subsite within the active site where 
a-COO' and a-H  bond cleavages take place. As observed in the crystal structure, the 
strategic position o f  Gln52 at the active site suggests a role in enhancing 
decarboxylation via formation of a hydrogen bond to the substrate carboxyl group. Ten 
Q52X mutants were constructed and their abilities to decarboxylate 2-methylalanine or 
transaminate L-alanine investigated. All mutants except Q52H exhibited decreased 
rates o f decarboxylation compared to WT. Results o f WT, Q52H and Q52N suggest 
that hydrogen bonding between the amide side chain o f WT or T-nitrogen on the 
imidazole ring of Q52H with substrate carboxyl group is required for decarboxylation. 
Mutants incapable o f  hydrogen bonding to substrate such as Q52A, Q52L and Q52W 
showed low decarboxylation activities, which are consistent with the proposed 
hypothesis.
32
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Replacement of Gln52 resulted in increased transamination rates for some 
mutants and decreased transamination rates for others. These data suggest that Gln52 
can influence the subsite environment that also catalyzes transamination. Furthermore, 
there is evidence demonstrating that the subsite environment of WT, Q52H and Q52E 
DGDs are different; the three DGD forms exhibited different chromophores at around 
A-max o f 500 nm when treated with either substrate in the presence of 3% glycerol. The 
concept o f  a catalytically isolated subsite within the DGD active site has important 
implications for OmAT and GabaAT, two medically important aminotransferases that 
are closely related to DGD. Point mutations in the OmAT subsite that catalyzes 
transamination could result in dysfunctional enzymes. Dysfunctional OmAT has been 
associated to gyrate atrophy, a hereditary disorder that leads to blindness in humans.
The amino acids at the GabaAT subsite could be alternative targets for drugs designed 
to inhibit GabaAT activity.
The concept of a catalytically isolated subsite within the DGD active site has 
important implications for OmAT and GabaAT, two medically important 
aminotransferases that are closely related to DGD. Point mutations in the OmAT 
subsite that catalyzes transamination could result in dysfunctional enzymes.
Dysfunctional OmAT has been associated to gyrate atrophy, a hereditary disorder that 
leads to blindness in humans. The amino acids at the GabaAT subsite could be 
alternative targets for drugs designed to inhibit GabaAT activity.
33
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2.2. Introduction
2,2 dialkylglycine decarboxylase (DGD; EC 4.1.1.64) from the soil bacterium 
Burkholderia (Pseudomonas) cepacia was first reported by Aaslestad and Larson (1964) 
and studied in some detail by several research laboratories (Bailey and Dempsey, 1967; 
Aaslestad et al., 1968; Lamartiniere et al., 1971; Honma et al., 1972; Sato et al., 1978). 
The native enzyme exists as a tetramer and its molecular weight has been estimated at 
180 kDa (Lamartiniere et al., 1971; Sato et al., 1978). The exact biological role o f DGD 
remains obscure; its widespread presence in many soil bacterial and fungal species 
(Dempsey, 1969; Esaki et al., 1994) suggests this enzyme probably plays an ecological 
role in the soil community. The DGD substrates, 2MA and isovaline, are found 
predominantly in cytotoxic peptides produced by soil fungi (Bruckner and Pryzbylski, 
1984). DGD may be involved in degradation o f fungal peptides to provide supplemental 
carbon and nitrogen sources for host bacteria (Keller et al., 1990).
Keller et al. (1990) reported the cloning, sequencing and expression of DGD 
gene into E. coli. Comparison of the 434 amino acid sequence of DGD with other PLP- 
dependent enzymes revealed that DGD is more similar to aminotransferases, in 
particular the carboxyl terminal o f rat ornithine aminotransferase where PLP-binding 
domain is located. No PLP-dependent decarboxylases showed significant homology 
with DGD. It has been suggested that DGD, being an aminotransferase, has acquired 
decarboxylation activity through evolution and not vice versa. Furthermore, Mehta and 
Christen (1994) designated DGD in one of the four major subfamilies o f PLP
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aminotransferases. Toney et al. (1995a) solved the 3D structure o f DGD and provided 
detailed analysis on the structural and mechanistic aspects o f the enzyme.
DGD is a unique PLP-dependent enzyme because it catalyzes two classical 
reactions, decarboxylation and transamination, at a single active site. Toney et al.
(1995a) proposed that there are three binding sites within the DGD active site and the 
exceptional ability of DGD to catalyze both reactions depends on the nature o f the 
binding sites. Toney et al. (1995a) also hypothesized that DGD decarboxylation could 
involve hydrogen bonding between the amide side chain o f Gln52 and the substrate 
carboxyl group. Gln52 and Lys272 that catalyze decarboxylation and transamination 
respectively reside at one of the three binding sites (Toney et al., 1995a). It is unknown 
whether decarboxylation and transamination reactions are separate events catalyzed by 
Gln52 and Lys272 respectively or are dependent on both residues for effective 
catalysis. However, the first concept is a simpler model to visualize: Removal o f Gln52 
abolishes decarboxylation but does not affect transamination; removal o f Lys272 
abolishes transamination but does not affect decarboxylation.
To test the validity of the hypothesis which states that Gln52 promotes DGD 
decarboxylation, Q52X DGD mutants were constructed, the proteins purified to near 
homogeneity and their abilities to decarboxylate 2MA or transaminate L-ala investigated. 
Mutant DGDs incapable o f hydrogen bonding to substrate at amino acid position 52 
cannot decarboxylate 2MA while their abilities to transaminate L-ala will remain 
unaffected. Conversely, mutants able to form hydrogen bonds with substrate carboxyl
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group will undergo a reduced rate o f decarboxylation; it is probable that the 
decarboxylation level may be enhanced by the amino acid substitution at position 52.
2.3. Materials and Method
Bacterial strains and media. E. coli strains used were JM109 (endAl, gyrA96, hsdR17(rk 
,mk ), mcrB+, recAI, relAI, A(lac-proAB), thi, supE44, F'[traD36, proAB, lac PZAM15], 
A )  and BHM 71-18 mutS (supE , thi-1, A(lac-proAB), F'fproAB+Jac PZAM15], m u tS :: 
TnlO). Competent cells were prepared according to the RbCl transformation procedure 
(New England Biolabs, 1994). Restriction enzymes were purchased from Promega. 
Bacterial media were M9/2MA (g/L: Na2HP04’7H20, 12.8; KH2PO4, 3; NaCl, 0.5; agar, 
15; thiamine, 0.040; glucose, 0.4%; 2MA, 10 mM), LB (g/L: tryptone, 10; yeast extract, 
5; NaCl, 10; agar, 15) and Terrific Broth (g/1.2 L: yeast extract, 28.8; tryptone, 14.4; 
glycerol, 4.8 mL; 120 mL 0.17 M KH2PO4, 0.72 M K.2HPO4 solution). Other reagents at 
final concentration included ampicillin (80 pg/mL), tetracycline (50 pg/mL), IPTG (0.5 
mM) and X-gal (20 pg/mL).
Construction o f DGD expression vector pDGDA2 (5986 bp). The dgdA gene was 
amplified from pUC19C7/7b, a plasmid derived from pUC19C7 by exonuclease removal 
o f about 1200 bp of non-coding DNA downstream of the dgdA gene (Keller et al, 1990). 
The amplification conditions were: 60 pL reaction volume containing 4 u Taq 
polymerase, 200 pM dNTPs, 1% formamide, 20 ng pUCl9C7/7b template, 1 pM primers 
JK2-20 and JK13 (Table I), lx  Taq buffer including 2.0 mM MgCL, and Milli-Q water
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(> 10 megohms-cm), 25 cycles at 97 °C/1 min, 55°C/0.5 min and 73°C/2 min. The 1462 
bp product was cut with EcoRl, the resulting 1396 bp EcoRl-EcoRl fragment was ligated 
to £co/?I-cut pBTacl (4590 bp, Boehringer-Mannheim, Amann et al., 1983), and was 
transformed into competent E. coli JM109.
Construction o f  Q52X DGD expression vectors by site-directed mutagenesis. Mutagenic 
(JK71p, JK76p and JK77p) and selection (JK72p) primers were purchased from GIBCO 
BRL (Table 1). Template pDGDA2 was prepared with Wizard™ Minipreps DNA 
Purification System (Promega) and made up to 50 ng/pL.
Q52X DGD mutants were constructed as outlined in the Transformer™ site- 
directed mutagenesis kit (Clonetech) which utilizes mutagenic and selection primers to 
introduce specific base changes into a double stranded template. DNA template, selection 
and mutagenic primers (100 ng each) were added to a final volume of 20 pL in lx 
annealing buffer. A control was started which contained (100 ng each): control plasmid 
pUC19M, control primer 1 (Trans Oligo Nde I/Nco I) and control primer 2 (reversion of 
the amber stop codon in the lacZ gene on pUC!9M) were made up to 20 pL in lx 
annealing buffer. The tubes were heated at 100°C for 3 min and chilled immediately in 
ice water bath for 5 min. 3 pL lOx synthesis buffer, 4 u T4 polymerase, 4 u ligase and 5 
pL Milli-Q water were added. Reactions were kept at 37°C for 3.5 hrs and heated at 70°C 
for 10 min to inactivate the enzymes. Following primary restriction enzyme digestion, 
competent BMH 71-18 mutS cells were transformed with control and hybrid DNA.
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Table 1. Primers used in construction o f  pDGDA2 and genetic engineering of Q52X DGD mutants. Bold 
letters indicate changes made to construct Q52X, Q52E and Q52N/Q52K respectively. All primers, except 
JK2-20 and JK13, were 5 '-phosphorylated.
Primer Purpose Position on 
dgdA gene
Sequence (5 ’-> 3')
JK2-20 1 GCT GCA AGG CGA TTA ACT TG
JK13 b CCA CACi AAT TC"T ,\TQ  TCC CTG AAC C.AC GAT
JK71p mutagenic -  strand,
150 to 180 nt
pCC GCG CTC ATN NNC CCC GAC GTG
JK 72pc selection -r strand,
1410 to 1440 nt
pGC CAA AAC AGA ATC TAG ACT GCA GGT CG
JK76p mutagenic strand,
150 to 180 nt
pCC GCG CTC ATT TCC CCC GAC GTG
JK77p mutagenic + strand,
150 to 180 nt
pCC GCG CTC ATN TTC CCC GAC GTG
1 complementary to sequences outside an EcoRl restriction site in the adjacent pUC19 vector. 
b contained the 5'-end o f the dgdA gene (start codon double underlined), plus a new EcoRl site (underlined). 
c underlined segment converted the only Hind III site on pDGDA2 to an equally unique Xba I site.
Table 2. Primers used in sequencing o f  WT and Q52X DGDs.
Primer Plasmid location Sequence (5’ -> 3')
JK5 20mer complementary to the first 20 nt 
o f  dgdA gene
ATG TCC CTG AAC GAC GAT GC
JK15 20mer complementary to dgdA 
coding strand 1106 to 1087 nt
CCT TGA CGA TCT CGA CGC CG
JK.17 20mer o f  lacZ coding strand o f  pBTacl, 
located upstream o f  cloning site o f pBTac
ATG TGT GGA ATT GTG AGC GG
JK25 25mer complementary to plasmid coding 
strand just outside vector-insert junction 
o f  pBTacl
GCT GAA AAT CTT CTC TCA TCC GCC A
JK41 20mer o f  dgdA coding strand 497 to 506 nt TTC GCG ATT CCG GCG CCA TT
JK43 20mer o f  dgdA coding strand 902 to 921 nt TTC TAT ACG ACG CAC GTG TC
JK46 20mer complementary to dgdA coding 
strand 595 to 566 nt
TCG AAC GCG TAG TCG AGT TC
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Cells were grown overnight and plasmid DNA isolated the next day. Following 
secondary restriction enzyme digestion, plasmids were transformed into JM109. Control 
cells were plated on LB/X-gal/TPTG/amp plates to determine extent of the primary and 
secondary enzyme digest. JM109 clones transformed with hybrid DNA that grew on 
LB/amp plates were selected and screened for mutant DGD.
Screening fo r  Q52X DGD mutants with selective growth medium. Screening JM109 
colonies carrying functional DGD is simplified by the inability o f E. coli to metabolize 
2MA (Keller et al., 1990). Expression of WT DGD carried on a vector maintained under 
antibiotic selection enables the bacteria host to grow on minimal medium containing 
2MA as sole nitrogen source. Bacteria expressing mutated forms o f DGD will grow 
slowly or not at all on M9/2MA/amp plates. JM109 Q52X DGD colonies were restreaked 
on fresh LB/amp master plates. Colonies were then blotted onto M9/2MA/amp plates and 
incubated overnight at 37°C. Colonies that grew poorly or did not grow cannot 
metabolize 2MA and therefore may have mutated forms o f DGD. These were selected 
from master plates and inoculated into 2 mL LB/amp tubes.
Automated DNA sequencing. Screening using automated DNA sequencing not only 
identifies mutants in targeted region, it also ensures that no extraneous mutations had 
occurred in other areas. Primers were prepared as 3 pM stocks (Table 2). Plasmid DNAs, 
purified using Wizard™ Minipreps, were sequenced with ABI Prism™ Dye Terminator 
Cycle Sequencing Ready Reaction Kit and AmpliTaq™ DNA polymerase FS.
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Sequencing reaction consisted of 400 ng plasmid DNA, 3 pL Prism™ mix, 3 pmol primer 
and Milli-Q water to 15 pL. Cycle sequencing was carried out in 200 pL thin wall tubes 
on a Perkin-Elmer GeneAmp® PCR Systems 9600 thermal cycler (96°C/10 sec; 50°C/5 
sec; 60°C/4 min; 25 cycles). Excess nucleotides were removed from the extension 
products by passing through Sephadex G-50 (Sigma) spin columns (Princeton 
Separations Centri-Sep™). Samples were analyzed on a 6.5% polyacrylamide gel by ABI 
373 DNA Sequencer Stretch. Sequence data were examined with ABI DNA sequencing 
analysis, 1.2.1 and GenePro, 6.10 (Riverside Scientific Enterprises, 1993). Previous 
experience showed that automated DNA sequencing o f  these vectors typically produces 
readable sequences between 600 to 700 bp long of 70 to 95% accuracy.
WTand Q52XDGD Expression and Enzyme Purification. Protein purification was 
modified from a previous procedure (Keller et al., 1990). TB/amp/EPTG was inoculated 
with two 2 mL LB/amp starter culture grown overnight. Cells were grown to stationary 
phase at 37°C, cooled to 4°C and pelleted (5,000 rpm, 15 min, 4°C, GSA head). The 
pellet was resuspended in 160 mL sonication buffer (50 mM Tris, 5 mM KC1, 5 mM 
NaCl, 1 M (NH4)2S04 , 2 mM NaPyr, 1 mM 2MA, 20 pM PLP at pH 7.9) and stirred
magnetically for 30 min in ice/water bath. Sonication was carried out with a Sonication 
Ultrasonic Processor and Cell Disrupter (Heat Ultrasonics System, Model W225) for lOx 
at 1 min intervals (40% duty cycle at a power setting o f  5) with cooling down periods to 
keep the suspension below 5°C. Protein concentration was determined with Bradford 
reagent (Bradford, 1976) at 596 nm after each sonication. Cell rupture was considered as
40
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completed when protein concentration showed no significant increase. Bacterial debris 
were removed by centrifugation (11,000 rpm, 30 min, 4°C, GSA head) and supernatant 
decanted into a clean flask. Ammonium sulfate was added to a final concentration of 2.2 
M. Protein precipitate was pelleted (11,000 rpm, 30 min, 4°C, GSA head), resuspended in 
40 mL dialysis buffer (20 mM TEA, 5 mM KC1, 5 mM NaCl, 2 mM NaPyr, 1 mM 2MA, 
20 pM PLP at pH 7.9), and dialyzed overnight in 2 L dialysis buffer at 4°C.
DEAE Toyopearl® 650M TSK-gel ion exchange matrix (Toyo Soda Mfg Co., 
Tokyo, Japan) was packed in a glass Bio-Rad chromatography column (30 cm x 3 cm) 
and pre-equilibrated with ion exchange buffer (20 mM TEA buffer, pH 7.9, 5 mM KC1, 5 
mM NaCl). The dialysate was loaded onto the column. The column was washed with ion 
exchange buffer until the O.D. at 290 nm returned to baseline. Protein elution was carried 
out with a salt gradient of 5 mM KC1, 5 mM NaCl to 250 mM K.C1, 250 mM NaCl (100 
mL each). Fractions were collected and protein content determined with Bradford 
reagent. Fractions containing 5 to 10 pg protein were analyzed with SDS-PAGE (Bio­
Rad Mini-PROTEAN® II Dual Slab Cell). SDS gels were scanned with IS-1000 Digital 
Imaging System (Alpha Innotech Corporation) to both locate fractions containing DGD 
and determine enzyme purity. Fractions of highest purity were pooled and desalted by 
eluting through a Bio-Rad Bio-Gel P-6DG gel column (50 cm x 1.5 cm, MW 
fractionation range o f  1,000 to 6,000) pre-equilibrated with 15 mM phosphate buffer, 40
,1fv
pM PLP, pH 6.75. Eluted fractions were again pooled and concentrated using Amicon 
Centricon-30 (30,000 MW cut-off) in a SS34 head (5,000 rpm, 4°C). The retained sample 
was rinsed with 500 pL of 50 mM phosphate buffer, pH 7.5 and further concentrated to 1
41
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mL final volume. Enzyme solutions, ranging from 20 to 30 mg/mL, were frozen in liquid 
nitrogen and kept in -70°C freezer as 50% glycerol stocks. Frozen enzymes were thawed 
on ice before use in the decarboxylation and transamination half reactions.
Decarboxylation and transamination h a lf reactions. Control experiments indicated that 
the enzyme activity showed little change over time when frozen at -70°C (result not 
shown). The decarboxylation and transamination half reactions consisted of 3.9 pM DGD 
(in 50% glycerol), 35 mM phosphate buffer, pH 7.5, 16 pM PLP and 56 mM 2MA/L-ala 
at 22°C. Holoenzyme was prepared as follows: 300 pg protein was diluted into 25% 
glycerol solution to final volume o f 50 pL, incubated with 80 pM PLP for 2 hrs and 
loaded onto CHROMA SPIN-10 columns (Clontech) and spun in a swinging bucket rotor 
at 1550 rpm for 4 min to remove unbound PLP. Reactions were carried out in 35 mM 
phosphate buffer, pH 7.5, 56 mM 2MA/L-ala and no PLP. The effect o f glycerol on 
reaction rates was also examined. Glycerol could be removed from enzyme solution by 
binding the enzyme to a small DEAE column (5 mm x 23 mm), washing and eluting with 
appropriate buffers as outlined in the previous section. Protein solution was 
reconcentrated with Ultrafree-MC microcentrifuge filters (NMWL 30,000). Half 
reactions with non-glycerol enzyme preparation were carried out as with 50% glycerol 
enzyme stock and 16 pM PLP. The first order rate constants of the half reactions were 
determined by monitoring the disappearance of PLP peak and appearance of PMP peak 
with Hewlett-Packard 8452A diode array spectrophotometer and UV-Visible 
ChemStation Software.
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2.4. Results
Construction o f  Q52X DGD expression vectors by site-directed mutagenesis. Ten 
plasmids expressing DGD mutants were isolated from recombinant JM109 (Table 3). 
Automated sequencing o f these plasmids using primers JK5 or JK17 and JK46 confirmed 
the presence of mutated nucleotide(s) at amino acid position 52. dgdA gene sequences 
outside the mutated region were sequenced with the other four primers (Table 2). The 
data agreed with the sequencing results using the manual Sanger dideoxy method 
(Brayman, 1993) except for two discrepencies. Previous sequencing misread GCC as 
GCG at A la312 and GTT as GTC at Val363. These degenerate third nucleotides do not 
alter identity o f the amino acid they code for. Hence, the protein sequence remains the 
same. Misreading o f the third nucleotide could be attributed to the difficulty in reading 
through a compressed GC rich region (United States Biochemical, 1993).
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Table 3. Plasmids with mutated DNA bases at amino acid position 52 on pDGDA2.
Mutant Plasmid Mutated DNA sequence Amino acid change
Q52A pSW22 CAG ->  GCG Gin -> Ala
Q52D pSW9 CAG ->  GAT Gin —► Asp
Q52E pSW l CAG ->  GAA Gin -> Glu
Q52G pSW12 CAG ->  GGC Gin -»  Gly
Q52H pSW306 CAG ->  CAC Gin —► His
Q52K pSW19 CAG -► AAG Gin —► Lys
Q52L pSW150 CAG ->  CTA Gin -> Leu
Q52N pSW59 CAG -► AAT Gin -»  Asn
Q52R pSW276 CAG -► CGA Gin -> Arg
Q52W pSW121 CAG ->  TGG Gin —> Trp
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WT and Q52XDGD Expression and Enzyme Purification. Bacterial pellets weighing 15 
to 20 g were harvested from 1.2 L o f TB medium. The purified WT and mutant DGDs 
were homogenous as indicated by a single band on SDS-PAGE. The mutant protein 
bands migrated the same distance as the WT enzyme. Scanning SDS gels with the IS- 
1000 Digital Imaging System determined enzyme purity at 90%. Ion exchange 
chromatography and P-6DG gel filtration elution profiles o f mutant DGDs were similar 
to WT DGD.
Decarboxylation and transamination ha lf reactions. A control experiment containing 
PLP and either 2MA or L-ala was set up to determine cofactor and substrate stability over 
time. The initial PLP shift from 390 to 400 run is due to the formation o f external 
aldimine between free PLP and amino acid; no further reaction could be detected. 2MA 
decarboxylation and L-ala transamination rates o f WT and mutant DGDs were shown in 
Table 4 and Figure 12. All reactions in Table 4 (enzyme concentration at 3.9 pM), except 
the last three, were carried out in excess PLP (16 pM). The last three reactions were 
conducted with holoenzyme preparations (i.e. PLP-bound enzymes) with no PLP added 
to the reaction. The rate o f  PLP disappearance is complemented by the rate o f PMP 
appearance during both half reactions in all DGDs examined. The synchronous 
disappearance o f the PLP peak and appearance of the PMP peak are indicative that the 
Q52X DGD mutants are able to carry out decarboxylation or transamination, although to 
some lesser extent than WT DGD.
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Table 4. Mutant DGD were tested for ability to decarboxylate 2MA and transaminate L-ala J.
DGD k  ( -C 0 2) b k  (-NH3) b Faster reaction (-NH 3 ) /( -C 0 2) c Notes
WT 38 44 (-NH 3) 1 . 2 peak at 500 nm. 
shoulder at 530 nm
Q52A 1.9 3.9 (-n h 3) 2 . 0
Q52D 1 2 67 (-N H 3 ) 5.8
Q52E 2.9 1 2 0 (-N H 3 ) 43 peak at 520 nm
Q52G 14 13 (-NH 3 ) = ( - c o 2) 1 . 0
Q52K d - - - no peak shift
Q52H 58 1 . 2 ( - c o 2) = 0 peak at 500 nm
Q52L < 1 . 0 1 . 6 {-n h 3) >1.6
Q52N 6.4 80 (-N H 3 ) 1 2
Q52R < 1 . 0 32 (-N H 3 ) >32
Q52W < 1 . 0 3.0 (-N H 3 ) >3.0
Q52D * 1 1 61 (-NH 3 ) 5.8
Q52H e 50 25 (-C 0 2) 0.5 peak at 500 nm
Q 52R ' 5.8 29 (-N H 3 ) 5.0
1 reaction consisted o f  3.9 pM  mutant DGD, 16 uM PLP, 56 mM 2MA/L-ala in 35 mM phosphate 
buffer, pH 7.5, carried out at 22CC. All reactions were carried out at least twice. Margin o f  error 
was about 5%. Final glycerol concentration was 3% v/v.
b (-C 02) = decarboxylation, (-N H 3) = transamination, k ( x 10“* s'1) is based on first order reaction 
where k ohs = 0.693 / 1| 2, and tIl2 is time required (in seconds) to reduce half o f  total A.U. o f PLP (or 
increase half o f  total PMP).
c Ratio o f  transamination rate versus decarboxylation rate. 
d no reaction was detected.
e mutant was incubated with excess PLP and eluted through Chromaspin columns, reaction 
conditions similar to 1 with no added PLP.
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Figure 12. 2MA decarboxylation and L-ala transamination rates o f WT and mutant DGDs. I’he last three reactions on the right 
were conducted with mutant DGD holoenzymes in the absence o f  free PLP.
4-ON
WT DGD exhibited decarboxylation and transamination rates o f  3.8 x 10'3 s '1 and 
4.4 x 10'3 s '1 respectively. Upon site-directed mutagenesis, DGD mutants exhibited an 
array of 2MA and L-ala reaction rates. All mutant DGDs, except Q52G and Q52H, 
catalyze transamination faster than respective decarboxylation; transamination rates range 
from 1.6 to 43 times higher than decarboxylation rates. More interestingly, Q52D. Q52N 
and Q52E catalyze transamination approximately 6, 12 and 43 times faster than 
respective decarboxylation. Under similar experimental conditions, Q52E was found 
incapable o f  decarboxylating D-ala (Figure 13).
If the transamination rates o f all DGD forms were then compared to that of WT, 
Q52E, Q52N and Q52D transaminate L-ala 2.8, 1.8 and 1.5 fold faster than WT 
respectively. In contrast, the relative decarboxylation rates o f the four DGD forms are 
reversed o f  transamination rates. Decarboxylation rate o f WT is the highest, followed by 
Q52D, Q52N and Q52E. Among the mutants engineered, Q52H is the only mutant 
showing significant level o f  decarboxylation. In fact it is 50% more efficient in 
decarboxylating 2MA than WT. However, Q52H transamination rate is almost 
undetectable.
Q52G decarboxylates 2MA and transaminates L-ala at similar rates. The reaction 
rates are also considerably lower than that o f WT. Q52K lacked any detectable activity. 
While Q52A, Q52L and Q52W showed residual decarboxylating and transaminating 
activities, Q52R exhibited insignificant decarboxylation rate but a significant level of 
transamination. The arginine mutant transaminates L-ala at appreciable rate, about 0.7 
times that o f  WT.
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Since it is possible that some of the low reaction rates were due to the inability of 
the mutants to catalyze more than one round of substrate turnovers. Holoenzyme forms of 
Q52D, Q52H and Q52R were prepared and assessed for their abilities to catalyze one 
round of substrate turnover (Table 4). Q52D and Q52R holoenzymes showed comparable 
half reaction rates to those preformed with 16 pM PLP. However, transamination rate of 
Q52H holoenzyme was 20-fold higher than that conducted with 16 pM PLP whereas the 
decarboxylation rate stayed relatively the same.
Figures 13 to 20 depict the decarboxylation and transamination reactions o f 
selected mutant DGDs with various substrates. 2MA decarboxylation and L-ala 
transamination o f WT DGD showed the concurrent decrease and increase in PMP and 
PLP peaks respectively (Figure 21).
Effect o f  glycerol on quinonoid formation and reaction rates. Addition of 3% v/v glycerol 
promoted absorption bands at roughly 500 nm in both half reactions of WT, Q52E and 
Q52H (Table 4). The appearance of the peak was accompanied by a pinkish color 
development in the reaction solution. The absorption peak at 500 nm has been designated 
as the quinonoid intermediate (Jenkins, 1964; Morino and Snell, 1967). WT exhibited 
•^max at 500 nm and a shoulder at 530 nm (Figure 21). The quinonoid intermediate of 
Q52H and Q52E showed X-max at 500 nm and 520 nm respectively (Figures 14. 15, 16 and 
17). Removal o f glycerol from the Q52H decarboxylation reaction showed no quinonoid 
peak as depicted in Figure 18. Q52N, the second fastest transaminase, showed no 
quinonoid peak in 3% v/v glycerol (Figures 19 and 20).
48
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Q52E7D-ala
Wavelength (nm)
Figure 13. Q52E/D-ala decarboxylation half reaction. Reaction conditions similar to 
those with other substrates. Scans were taken every 10 min. N o activity was detected in 
1 hr; the result is consistent with the hypothesis that the carboxyl group o f  D-ala was 
oriented towards GIu52 and not decarboxylated.
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Figure 14. Q52E/2MA decarboxylation half reaction. Reaction: 3.9 pM holoenzyme, 56 mM 
2MA in 35mM phosphate buffer, pH 7.5 at 22°C. Scans were taken at 0, 10. 30 and 60 min 
after protein addition (a -  d). The 520 nm peak appeared immediately after protein was added.
Q52E/L-ala
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Figure 15. Q52E/L-ala transamination half reaction. Reaction: 3.9 pM holoenzyme, 56 mM 
L-ala in 35mM phosphate buffer, pH 7.5 at 22 °C. Scans were taken at 0, 1, 5, 10. 20, 30 and 
40 min after protein was added (a -  g). A peak absorbing maximumly at 520 nm was noted.
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Figure 16. Q52H/2MA decarboxylation half reaction. Reaction: 3.9 uM holoenzyme, 16 u.M 
PLP, 56 mM 2MA in 35 mM phosphate buffer, pH 7.5 at 22°C. Scans from 300 to 600 nm 
were taken at 0, 5, 10, 20, 30, 60 and 100 min after addition o f  protein (a -  g). Appearance of 
an absorption peak at 500 nm was noted.
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Figure 17. Q52H/L-ala transamination half reaction. Reaction: 3.9 pM holoenzyme, 56 mM 
L-ala in 35mM phosphate buffer, pH 7.5 at 22 °C. Scans from 300 to 600 nm were taken 
before adding the enzyme (a); 0, 5, 15, 25 and 30 min after protein was added (b). The 500 
nm peak appeared immediately after protein was added and reached maximum absorption 
after 5 min.
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Figure 18. Q52H/2MA decarboxylation half reaction without glycerol. Reaction conditions 
similar to that using protein with added glycerol. Scans were taken at 0, 1. 2, 3, 5, 10, 15 and 
20 min after addition o f  Q52H (a -  h). Note the absence o f  absorption band at 500 nm.
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Figure 19. Q52D/2MA decarboxylation half reaction. Conditions similar to those in Figures 
13 and 16. Scans were taken at 0, 0.5. 1 to 10 hrs (a -1). Note the absence o f  the 500 nm 
absorbing peak.
Q52D/L-aIa
wavelength (nm)
Figure 20. Q52D/L-ala transamination half reaction. Conditions similar to those in Figures 14 
and 17. Scans were taken at 0, 0.25. 0.5, 1, 2, and 3 hrs after protein was added (a -  f).
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Figure 21. WT/2MA decarboxylation half reaction and WT/L-ala transamination half reaction. 12.5 pM 
WT DGD pre-incubated with 85 pM PLP in 50 mM phosphate buffer, pH 7.5 at 22°C for 1 hour. 50 mM 
2MA (A and C) or L-ala (B and D) were then added. C and D: reactions were monitored at 300 nm ( ♦  ), 
390 nm or 400 nm ( ), 500 nm ( •  ) and 530 nm ( O ). o f  PLP-enzyme complex in (C) and (D) are
390 nm and 400 nm respectively. Final glycerol concentration was 3% v/v.
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Presence of glycerol did not alter reaction rates of selected DGD forms (Table 5). 
The only pronounced difference is the absence o f a quinonoid peak in reactions with no 
added glycerol. Figures 21C and D indicated that, at least in the WT DGD reaction, the 
quinonoid formation and decay over time is dependent on the presence of glycerol and 
not 2MA or L-ala.
Table 5. Effects o f  glycerol1 and without glycerol b on WT and mutant DGD decarboxylation 
and transamination reaction rates. Reactions described in method section, similar to those in 
Table 4 . c (-C 02) = decarboxylation o f 2MA, (-NH 3) = transamination o f  L-ala.
PLP DGD k (-CO2)c k (-NH3)C
16 pM W T 1 37.7 43.8
W T b 33.5 49.8
16 pM Q52E 1 2.89 125
Q52E b <1.00 107
16 pM Q52N 4 6.42 79.5
Q52N b 5.50 77.0
Enzyme bound Q52H 1 50.2 24.6
Q52H b 52.5 19.3
2.5. Discussion
WT and Q52X DGD Expression and Enzyme Purification. Q52X DGD mutants exhibited 
similar migrating distance compared to WT DGD in SDS gels, implying the Q52X 
subunits have similar molecular weights as that o f the native enzyme. The comparable 
elution volume in the P-6DG size exclusion chromatograms suggested that the mutants, 
like the WT enzyme, exist as tetrameric structures. The ion exchange chromatography 
elution profiles o f mutant DGDs were similar to WT DGD. This implies that the total 
charges on protein surface and therefore the nature of protein interaction of mutant DGD
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with DEAE matrix was similar to WT DGD. Conceivably, base changes in amino acid 
position 52 posed no significant structural changes in these proteins.
The codons chosen at the mutated region could effect the level of expression of 
mutant DGDs in E. coli. Two observations could be made from the E. coli codon usage 
database compiled from CUTG (Codon Usage Tabulated from Genbank, release 102; 
Appendix 1): (1) strongly expressed codons such as CAG, GAT and GAA (code for WT, 
Q52D and Q52E respectively) yield higher levels o f recombinant protein production of 
almost 4 mg/g wet cells; (2) weakly expressed codons such as CTA and CGA (code for 
Q52L and Q52R respectively) show mutant protein production o f about 2.4 mg/g wet 
cells. The 2-fold increase in level of expression warrants the use o f strongly expressed 
codons when overproducing mutant DGD in E. coli JM109 (refer to Appendix 2 for 
protein production o f mutant DGDs).
Decarboxylation and transamination half reactions o f  WT and Q52X DGDs. 
Replacement of Gln52 with other residues affected both decarboxylation and 
transamination to different extent. In most instances, decarboxylation rates exhibited 
marked decreases. On the other hand, transamination rates o f some mutants increased 
while others decreased. The experimental results support the hypothesis that hydrogen 
bonding promotes decarboxylation. Since hydrogen bond formation may be the requisite 
for release o f substrate COO', Q52X mutants able to bond with substrate a-group 
perpendicular to the 7r-pyridine ring were considered. Mutants Q52D, Q52E, Q52N and 
Q52H fall under this category. These mutants were then arranged in the order of
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
57
increasing decarboxylation and transamination rates with accordance to results in Table 4 
and Figure 12.
Among the five forms of DGD, Q52H is the fastest ‘decarboxylating’ mutant and 
also the slowest in transaminating L-ala. However, Q52E is the opposite of Q52H; it is 
most apt at transaminating L-ala but decarboxylates 2MA poorly. Although Q52E and 
Q52H showed impressive potential to transaminate and decarboxylate substrates 
respectively, they were likely ruled out through the course o f  evolution because of their 
inefficiencies in catalyzing the other half reaction. The most surprising finding is that WT 
is not the most perfect enzymatic form to perform decarboxylation or transamination; 
glutamine is the preferred residue because both reactions could be carried out at the best 
possible rate.
Histidine (H), glutamine (Q) and asparagine (N) at strategic position in proteins 
provide clues into how enzymatic activity could be influenced by potential hydrogen 
bonding between the amino acid side chain and substrate (Lowe et al., 1985; Vaalar and 
Snell, 1989). According to Lowe et al. (1985), the t-N and n-N o f histidine could be 
superimposed by side chain amide groups of glutamine and asparagine respectively 
(Figure 22).
Rate o f decarboxylation 
Rate o f transamination
Q52H > WT > Q52D > Q52N > Q52E 
Q52E > Q52N > Q52D >  WT > Q52H
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Figure 22. Amino acid side chain at position 52 capable o f  hydrogen bonding.
WT decarboxylation rate is 0.7 and 6 fold o f  Q52H and Q52N respectively, 
whereas the transamination rate is 1.7 and 0.6 times o f Q52H and Q52N respectively. 
DGD decarboxylation is more affected by the replacement o f Gln52 while transamination 
capability is less critical o f the mutated residues. x-N o f histidine compensates glutamine 
amide side chain and also partially enhances the decarboxylation step. On the other hand, 
ti-N o f histidine does not participate in hydrogen bonding as evident by the lack of Q52N 
decarboxylation. Hence, the glutamine amide side chain and histidine x-N are important 
for hydrogen bonding in facilitating decarboxylation. Furthermore, slow reaction rates o f 
Q52L and Q52W, which are not potential hydrogen bond donors, supported the concept 
o f hydrogen bonding between Gln52 and substrate.
The Q52H decarboxylation rate is the highest o f  all the mutants studied and is 1.5 
times faster than WT. Under physiological conditions, histidine can act as a general
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acid/base catalyst or as a hydrogen bond donor to substrate. The following reasoning is 
provided to explain hydrogen bonding between the protonated imidazole ring and 2MA. 
Keller et al. (1997) reasoned that pKa o f Gln52 has to match that of substrate carboxylate 
group for productive hydrogen bonding that enhances decarboxylation. Since the pKa of 
glutamine is higher than histidine under normal conditions (i.e. out o f the active site), the 
microenvironment at the active site needs to lower the pKa o f Gln52. Histidine with pKa 
of 7 is better at enhancing 2MA carboxylation.
Q52G could be regarded as a reference point for other mutants. Lacking a polar, 
charged or hydrophobic side chain, Q52G typifies an environment in the active site 
pocket where no amino acid occupies position 52. Nevertheless, under the influence of 
other active site residues (e.g. Tyr301) and/or the active site microenvironment, 2MA 
decarboxylation and L-ala transamination rates are 1/3 those o f WT. The reaction rates of 
Q52A, Q52L and Q52W DGDs could be considered negligible because they lagged 
behind those of Q52G. An important inference can be made from these mutants: A 
hydrogen bond (or ionic interaction) between the substrate and the active site residue is 
important in DGD-catalyzed decarboxylation and transamination reactions. Toney et al. 
(1990a) predicted DGD decarboxylation is enhanced by the presence o f Gln52 but did 
not expect transamination activity to be influenced by Gln52. Keller et al. (1997) 
proposed that the DGD active site is more hydrophobic compared to other 
aminotransferases. Hydrophobic environment has been attributed to accelerate 
decarboxylation rate (Marlier and O’Leary, 1986). This hydrophobicity requirement is
59
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fulfilled by the aromatic rings o f  Tyr301* and Phe79* surrounding Gln52. However, in a 
hydrophobic active site, DGD-catalyzed transamination may require additional 
interactions between the substrate and the active site residues, such as hydrogen bonds, 
for the reaction to be carried out effectively.
The inactive enzyme form Q52K could be attributed to the close proximity of 
Lys52 to Lys272; Lys52 may interfere with substrate binding or prohibit the substrate 
from forming external Schiff base, a prerequisite for PLP-dependent catalysis. Arginine 
forms strong bifurcated hydrogen bonds with the carboxyl group o f 2-methyl-L-aspartate 
in two o f the binding sites in AAT (Okamoto et al., 1994). Similar observation was noted 
in Q52R. The carboxyl group o f  2MA was held in place by Arg52 but no reaction took 
place, resulting in undetectable decarboxylation rate.
Effect o f  side chain length on decarboxylation and transamination. The carboxyl 
ends of Q52D and Q52E increase transamination but depress decarboxylation. In fact, 
decarboxylation rates o f both mutants are slower than Q52G (control) and comparable to 
those of Q52L and Q52W (bulky R groups). One possible explanation is that electrostatic 
repulsion between side chain and substrate carboxyl groups prevents 2MA from being 
oriented properly at the active site. In Q52E, the negligible D-ala reaction rate agreed 
with that o f 2MA. Both substrates are oriented at the active site for decarboxylation. 
However, the carboxyl side chain of Q52E repels the substrate carboxyl group, thus 
resulting in non-productive reaction.
* denotes amino acid o f the other monomer in the dimeric structure
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Q52E transaminates faster than Q52D. It is possible that GIu52, and not Lys272, 
catalyzes proton abstraction. This suggestion arises from van Poelji et al. (1990) who 
investigated the catalytic role o f Glu214 o f pyruvoyl-dependent histidine decarboxylase 
from Clostridium perfringens. They proposed that by recycling between the ionized and 
unionized forms, Glu214 protonates the quinonoid intermediate after the decarboxylation 
step. By similar reasoning, the ionized Glu52 could abstract a proton from L-ala. Again, 
Glu52 is more effective in deprotonating L-ala since the abstracted proton is within reach 
by the longer carboxyl side chain o f Q52E. Another possible explanation is that Asp52 
and Glu52 enhances the basicity o f Lys272, thus increasing the rate of proton abstraction 
(Figure 23).
Multiple substrate turnovers in Q52D, Q52H and 052R DGDs. Judging from the reaction 
rates o f holoenzymes with those in excess PLP, Q52D and Q52R can catalyze multiple 
substrate turnovers. Q52H transamination exhibited negligible multiple substrate turnover 
rates. PLP or 2MA (or both) intake into the Q52H active sites may be somewhat limited
Lys272
Asp52, Glu52—  COO".
hydrogen
bonding
^  from L-ala 
transamination
Figure 23. Enhanced basicity o f  Lys272 by Asp52 and Glu52.
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after the first substrate turnover. At present, explanation o f the results awaits more in­
depth experiments.
Quinonoid formation in WT, Q52E and Q52H DGDs. Appearance o f an absorption band 
near 500 nm in PLP-dependent enzymes is fairly common under certain conditions. 
Substrate analogs (Zakomirdina et al., 1989; Ben-Kasus et al., 1996; Philips et al., 1997), 
addition o f organic solvent (Faleev et al., 1994; Ahmed et al., 1996) and site-directed 
mutagenesis o f active site lysine to arginine (Philips et al., 1991; Toney et al., 1991) are 
some o f the methods employed to induce quinonoid intermediate. This report 
demonstrated addition of glycerol and normal substrates induce quinonoid formation in 
WT and certain mutant DGDs. The absorption band, representing the quinonoid 
intermediate, is observed in both half reactions with glycerol; the band disappears as 
reaction progresses. This red peak formation can be eliminated when glycerol is removed 
from the enzyme preparation. Glycerol does not alter reaction rates since the three forms 
o f DGDs tested showed similar decarboxylation and transamination rates with and 
without glycerol. It is unclear how glycerol induces formation of the quinonoid 
intermediate. Faleev et al. (1994) proposed water-organic solvent could distort or 
interfere with proper orientation of the basic catalytic group within enzyme active site. In 
this case, the decreased ability o f Lys272 to reprotonate the quinonoid intermediate could 
account for the appearance o f transient peak in WT, Q52E and Q52H. Isupov et al.
(1998) cited that their preliminary data on a quinonoid complex of tryptophanase suggest 
that the serine residue in the active site Ser-X-X-Lys motif could hydrogen bond to
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Lys266 in the external aldimine and/or quinonoid steps o f the reaction. Similarly, Thr269 
could hydrogen bond to Lys272 during the quinonoid step in DGD. The increasingly 
hydrophobic environment may have slowed down the release of Lys272 from Thr269, 
thus impeding the reprotonation step o f the quinonoid intermediate. Nevertheless, further 
speculation on this scenerio is not attempted with the limited information provided by 
Isupov et al. (1998). Alternatively, a yet-to-be determined active site residue could be 
catalyzing the reprotonation step and is affected differently by the more hydrophobic 
environment.
Decarboxylation or deprotonation o f the external aldimine produces quinonoid 
intermediate absorbing maximally at different wavelengths in Q52E, Q52H and WT 
DGDs. Q52E and Q52H showed singular / w x at 520 nm and 500 nm respectively 
whereas WT showed dual peaks at 500 and 530 nm. So far, the possibility that the 
quinonoid complex (Figure 24) could account for the difference in a^ x is eliminated 
since the transient species exhibited similar Xmax in both 2MA and L-ala half reactions. 
The only deviating factors among the three DGD forms are the leaving group of the 
PLP/substrate complexes and the replacement of amino acid at position 52. The leaving 
groups o f the PLP/substrate complexes were similar in the three DGD forms and 
therefore could not have affected the 7-max. The final possibility is that the replacement o f 
Gln52 with histidine and glutamate changed the subsite environment substantially enough 
to shift A-max o f the intermediates. The subsite is catalytically, if not physically, isolated 
from the rest o f the DGD active site. Any amino acid mutation within the subsite will 
affect the microenvironment within that subsite.
63
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Figure 24. Quinonoid intermediates in L-ala-PLP and 2MA-PLP complexes.
OrnAT and GabaAT active sites. The concept o f a catalytically isolated subsite within 
the DGD active site has important implications for OmAT and GabaAT, two medically 
important aminotransferases that are closely related to DGD. Gyrate atrophy, a 
hereditary disorder that leads to blindness in humans, can be traced to dysfunctional 
OmAT (Shen et al., 1998 and references therein). Point mutations in the OmAT genes 
are detected in patients suffering from gyrate atrophy. The rational that an enzyme 
lacking a catalytically or structurally important residue can result in a dysfunctional 
enzyme is applicable to OmAT. Since OmAT is structurally related to DGD, both 
active sites may share similar features. DGD catalytic ability was compromised when 
one of the active site residues was mutated. Similarly, the catalytic ability o f OmAT 
could alter if  the point mutations code for an amino acid is located at the subsite.
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Presently, the anti-epileptic drug, vinyl-GABA, inactivates GabaAT by forming 
an a,(3-unsaturated ketimine, then an enamine that tautomerizes (Toney et al., 1995b). 
The amino acids at the GabaAT subsite could be alternative targets for drugs designed 
to inhibit GabaAT activity.
2.6. Conclusion
Experimental results supported the hypothesis that hydrogen bonding to the 
substrate carboxyl group is crucial for the ability o f DGD to carry out decarboxylation. 
However, transamination rates o f the Q52X DGD mutants were affected; transamination 
rates for some mutants increased while others decreased. In the DGD-catalyzed 
transamination, hydrogen bonding (or ionic interaction) between substrate and active site 
residues becomes an important factor in ensuring reaction takes place in a hydrophobic 
active site environment. Decarboxylation and transamination reactions are not mutually 
exclusive events as previously perceived; replacement o f Gln52, which is proposed to 
catalyze decarboxylation, has a profound effect on the DGD transamination ability.
WT DGD is not the optimal enzyme form for catalyzing decarboxylation or 
transamination. Nevertheless, glutamine is the preferred residue because it catalyzes both 
half reactions at reasonable rates.
Addition of 3% v/v glycerol did not affect decarboxylation and transamination rates 
in WT, Q52E and Q52H DGDs but induced the formation of long-wavelength absorbing 
intermediates in the three DGD forms. These absorption peaks are generally attributed to 
the accumulation of quinonoid intermediates. The different of the quinonoid
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intermediates in the three DGD forms suggest that the subsite is catalytically, if  not 
physically, isolated from the rest o f  the DGD active site. Any amino acid mutation within 
the subsite will affect the microenvironment within that subsite.
The concept of a catalytically isolated subsite within the DGD active site has 
important implications for OmAT and GabaAT, two medically important 
aminotransferases that are closely related to DGD. Point mutations in the OmAT 
subsite that catalyzes transamination could result in dysfunctional enzymes. 
Dysfunctional OmAT has been associated to gyrate atrophy, a hereditary disorder that 
leads to blindness in humans. The amino acids at the GabaAT subsite could be 
alternative targets for drugs designed to inhibit GabaAT activity.
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Chapter 3 
Evolutionary relationships between 2,2-dialkylglycine decarboxylase 
(DGD) and PLP-dependent enzymes: Investigations into amino acids 
responsible for DGD decarboxylation
3.1. Abstract
Protein sequence alignment revealed that 2,2-dialkylglycine decarboxylase 
(DGD) is closely related to PLP-dependent aminotransferases (Mehta and Christen, 
1994). However, DGD possesses the ability to decarboxylate amino acids not found 
within the family. More intensive protein sequence comparison and computer protein 
modeling were undertaken to investigate this unique ability of DGD. All four invariant 
residues o f structural and functional importance found in all PLP aminotransferases were 
verified in DGD [Gly216 (314AT2), Asp243 (340AT), Lys272 (385AT) and Arg406 
(562AT)].
Gln52 and one of the histidines near the active site are thought to contribute to 
DGD decarboxylation activity. Even though DGD decarboxylation depends on Gln52 
and therefore probably the amino terminus, no known decarboxylases share substantial 
similarity with the amino end of DGD. Aminotransferase subgroup I and II members, 
except ornithine aminotransferase (OmAT), lack residues at position 52 capable
2 refers to the numbering system o f  amino acid applicable to aminotransferases (AT) in general (Mehta et 
al., 1993).
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of hydrogen bonding with substrate carboxyl group. Even then, Tyr85 OmAT, which 
corresponds to Gln52 DGD, does not hydrogen bond with analog carboxyl group but 
participates in enzyme inhibition via ring to ring interaction. More importantly, the 
protein backbone dictates the exact position o f Gln52 for optimal interaction with the 
substrate carboxyl group. This is evident by the position o f the corresponding Val39 of 
aspartate aminotransferase (AAT), which faces away from substrate due to a slight turn 
of the protein main chain.
Two out o f the seven histidines could be partly responsible for DGD 
decarboxylation. His77 and 304 are part o f  a network that coordinates the potassium ion 
and are in close proximity to Gln52. The potassium ion requirement in DGD 
transamination or decarboxylation or both reactions is unknown. His77 and 304 
mutations in wild-type DGD, Gln52 to His52 mutant (catalyzing decarboxylation only) 
and Gln52 to Glu52 mutant (catalyzing transamination only) may provide clues to solve 
the mystery.
3.2. Introduction
PLP-dependent enzymes are divided into a number of families that catalyze 
distinctive reactions; the largest family by far is the a  family (Christen et al., 1994). The 
a  family enzymes, with few exceptions, carry out reactions at the substrate a  carbon. 
Among the members are most aminotransferases, which catalyze the reversible amino 
transfer o f  amino acids and oxo acids. Analysis by multiple protein sequence alignment 
revealed that aminotransferases belong to a single family o f homologous proteins (Mehta
68
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et al., 1993). Although these enzymes are grouped into one family, they exhibit an array 
o f substrate specificity. Mehta and co-authors further divided the aminotransferases into 4 
subgroups, based on their degree of similarities in primary structure. Conceivably, the 
earliest enzymes were reaction specific and evolved divergently to become substrate 
specific (Christen et al., 1994). In contrast, PLP decarboxylases are classified in at least 
four evolutionary unrelated groups (Christen et al., 1994). Decarboxylases exhibiting the 
same substrate specificity can be unrelated at the amino acid sequence level. Likewise, 
decarboxylases within the same organism, e.g. arginine decarboxylases in E. coli, can be 
o f different lineages. PLP decarboxylases thus represent an example o f convergent 
evolution in B& enzymes.
Keller et al. (1990) showed that the overall DGD sequence is most similar to 
ornithine aminotransferases (OmAT), in particular rat OmAT. Both DGD and rat OmAT 
shared 56% homology at the carboxyl termini where the PLP-binding domain is located. 
They also addressed the question of whether DGD, being an aminotransferase, has 
acquired decarboxylation activity through evolution or vice versa. Based on sequence and 
structural similarities, DGD is most related to subgroup II (Mehta and Christen, 1994), 
one o f the four major subfamilies o f PLP aminotransferases (Mehta et al., 1993). While 
most members within subgroup II only transaminate substrates, DGD carries out 
sequential decarboxylation and transamination. Apparently, DGD has evolved from the 
aminotransferases only after the enzymes had specialized into subgroups.
Toney et al. (1995a) postulated that the ability o f DGD to catalyze 
decarboxylation in addition to transamination could be explained by the strategic
69
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presence o f Gln52 at the enzyme active site. The singular presence o f  Gln52 in DGD, and 
not in other PLP enzymes, can promote decarboxylation by first forming a hydrogen 
bond with the substrate carboxyl group. In addition, Sato et al. (1978) presented evidence 
o f an important histidine residue in DGD decarboxylation activity. Chemical inactivation 
o f a histidyl residue inhibited decarboxylation selectively and converted DGD into a 
simple aminotransferase. The DGD primary sequence showed that the enzyme lacks the 
typical histidine-lysine pair at the active site o f decarboxylases. Nevertheless, Keller et al. 
(1990) speculated a histidine, not adjacent to lysine but present elsewhere at the active 
site, may still be required for the decarboxylation half reaction. It is probable both Gln52 
and one o f the seven histidines in DGD are required for decarboxylation. Primary 
sequence alignment of subgroup II members and DGD may provide insight into how 
Gln52 as well as which histidine allow DGD to catalyze decarboxylation. In other words, 
residues o f other enzymes at positions equivalent to DGD Gln52 and histidines could 
explain the roles these amino acids play in DGD decarboxylation.
Since Gln52 is located at the amino end, it is hypothesized that the N-terminus of 
DGD could be responsible for catalyzing decarboxylation. Is DGD more homologous to 
decarboxylases at its amino end but retains its aminotransferase characteristics at its 
carboxyl end? It may be possible to locate within protein databases sequences 
homologous to DGD amino end and coincidentally a decarboxylase. The objective o f the 
following study was to use protein sequence comparison to elucidate the relationships of 
DGD with aminotransferases and decarboxylases, as well as gain an understanding of 
which specific residues contribute to DGD decarboxylation.
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3.3. Method
Using the BLAST (Basic Local Alignment Search Tool, Altschul et al., 1990),
140 amino acids from the DGD N-terminus were compared to known amino acid 
sequences from Genbank (releasel03), Brookhaven Protein Data Bank (release 82), 
Swiss-Prot (release 34) and NBRF-PER (release 54). Protein sequences o f positive hits 
from the search were compiled in a databank. Multiple sequence alignments were carried 
out using Omiga 1.0.1 Clustal W algorithm with default parameters (Oxford Molecular 
Group, 1997). Protein sequence homology was scored with GenePro 6.10 (Riverside 
Scientific Enterprise, 1994). 3D enzyme structures were downloaded from Brookhaven 
Protein Data Bank (release 82) and visualized with Sybyl 6.2 (Tripos, 1995) or RasMol 
2.6 (R. Sayle, 1995).
3.4. Results
Mehta et al. (1993) located four invariant residues of structural and functional 
importance in 51 sequences o f PLP aminotransferases. Mehta and Christen (1994) found 
DGD only fulfils two such requirements; Lys272 forms a Schiff base with cofactor and 
Asp243 pairs with pyridine N o f coenzyme. By using the Omiga 1.0.1 multiple alignment 
algorithm and 3D structural information, two additional residues were located that allow 
DGD to be categorized as an aminotransferase. The following four residues in DGD are 
involved in the designated functions described previously (Mehta et al., 1993). (1)
Gly216 (314AT) participates in type I P-tum sandwiched between the large PLP binding 
domain and the smaller C-terminal domain; (2) Asp243 (340AT) forms a salt
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bridge/hydrogen bond to N1 of pyridoxal 5’-phosphate; (3) Schiff base formation takes 
place at Lys272 (385AT) and (4) a-carboxylate group o f substrate is oriented by Arg406 
(562AT).
Protein sequence comparison o f  Gln52 DGD to aminotransferase subgroups I  and II. 
Alignment o f Gly42 to Ser54 DGD with AAT, a member o f subgroup I, is shown in 
Table 6. DGD is less related to AAT as evident by homology scores o f 13 to 15% with 
prokaryotic, cytosolic and mitochondrial AATs. AAT valine or alanine occupies the 
position corresponding to Gln52 of DGD; these residues are incapable o f hydrogen 
bonding.
The BLAST algorithm search showed that only PLP aminotransferases subgroup 
II share significant amino terminal homology with DGD. Search results also indicated 
that although DGD decarboxylation depends on Gln52, no known decarboxylases share 
substantial similarity with amino end o f DGD. The six aminotransferases showing 
significant homology at the amino termini are acetylomithine (AcomAT), alanine- 
glyoxylate (AGAT), 4-aminobutyrate (GabaAT), co-amino acid-pyruvate (omega-APAT), 
ornithine (OmAT) and 7,8-diamino-pelargonate (DapaAT) aminotransferases. Two PLP 
aminotransferases from Caenorhabditis elegans and Bacillus firm us whose functions 
have yet to be determined were also listed as positive hits. DGD not only shares 
significant homology with subgroup II members in terms o f overall sequences (Mehta 
and Christen, 1994) but also N-terminal sequences.
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Table 6 . Gly42 to Ser54 DGD compared to AAT, member o f PLP aminotransferase subgroup I.
Enzyme Source % homology to DGD 1 References
DGD Burkholderia cepecia G R A 1 L D F T S G
1
Q M S Toney et al. (1995)
AAT Escherichia coli 13 P G K - 1 N L G 1 G V Y K Okamoto et al. (1994)
AAT pig cytosolic 13 P R K - V N L G V G A Y R Arnone ct al. (1985)
AAT chicken cytosolic 14 S R K - V N L G V G A Y R Borisov ct al. (1985)
AAT chicken mitochondria 15 S K K -  M N L G V G A Y R McPhalen et al. (1992)
Concensus G *
* denotes Q52 DGD aligned with V or A of subgroup I aminotransferases
-jOJ
Seventeen subgroup II aminotransferases from different sources were tabulated 
and their sequences compared to DGD (Table 7). Homology scores between DGD and 
subgroup II members range from 32 to 19%. B.firmus aminotransferase shares the most 
sequence similarity with DGD; 32% o f DGD 433 amino acids aligned with 445 residues 
o f B.firm us aminotransferase. M. tuberculosis 4-aminobutyrate aminotransferase scores 
30% homology with DGD.
Glycine and proline residues occupy similar positions in primary sequences o f 
subgroup I and II enzymes (Tables 6, 7 and 8). Both amino acids are conserved for 
structural purposes; these residues allow specific main chain conformations in proteins 
unattainable with other amino acids. Within the DGD structure, residues Gly42, Gly51 
and Pro308 participate in (3 turns between helixes (Toney et al., 1995a). Conservation of 
glycines and prolines in primary sequences is usually an indication that the proteins are 
folded into similar shapes and hence belong to the same enzyme family (Branden and 
Tooze, 1991). Additionally, the similarity o f the 3D structures o f AAT, OmAT, DGD and 
tryptophanase attest to the fact that these enzymes are homologous.
Gly42 to Ser54 of DGD alignment with subgroup II yielded one other consensus 
residue: aspartate is most likely conserved for functional purposes since the residue can 
form hydrogen bond (Table 7). Asp47 of DGD is located at the carboxyl end o f the three 
stranded antiparallel P-sheets in the N-terminal segment (see pp. 18) and participates in 
type I P-tum (Toney et al., 1995a). It is very likely that aspartate at the corresponding 
positions in other members take part in similar bonding. The most noteworthy finding is 
that Gln52 DGD aligned with isoleucine (AcomAT, AGAT and GabaAT), leucine
74
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Tabic 7. Gly42 to Ser54 DGD compared to PLP aminotransferases subgroup II.
Enzyme________ Source_________________ % homology to DGD__________________________________________I________________References
DGD Burkholderia cepacia G R A 1 L D F T S G Q M s Keller et al. (1990)
AcomATag A Intis glulinosa 27 G R E Y L D L S A G I A V Guan et al. (1996)
AcomATec Escherichia coli 22 G K E Y V D F A G G 1 A V Heimbcrg et al. (1990)
AcomATkl Kluyveromyces lactis 23 N K E Y 1 D F T A G 1 A V Janssen et al. (1997)
AcomATs Synechocystis PCC6803 28 G K S Y L D F V A G 1 A T Kancko et al. (1996)
AcomATy yeast 22 G K E Y 1 D F T A G I A V Hcimberg et al. (1990)
AGATm mouse 25 G N R Y L D F F S G 1 V T Lee et al. (1995)
ATbf Bacillus firmus 32 G V K Y L D F T S G I A V Quirk and Krulwich (1991)
ATce Caenorhabilitis elegans 22 G K K Y L D F F G G 1 V T Wilson et al. (1994)
GabaATan Aspergillus nidulans 20 G N M L L D V Y A Q 1 A S Richardson et al. (1989)
GabaATmt Mycobacterium tuberculosis 30 G N R L 1 D L G S j D  1 A V Conner et al. (1996)
GabaATy yeast 19 G N T Y L D L Y A Q 1 S S Andre and Jauniaux (1990)
omcga-APATpp Pseudomonas putida 24 G R K V Y D S L S _ G ] L W T Yohana et al. (1992)
OmAThu human 24 G R K Y F D F L S S Y S A lnana ct al. (1986)
OrnATrn mouse 23 G R Q Y F D F L S A Y G A Muccklcr and Pitot ( 1985)
OmATy 1 yeast 22 G K L Y L D F L s A Y S A Degols (1987)
DapaATbs Bacillus sphaericus 24 N Q R Y I. D A V s S W w V Gloccklcr at al. (1990)
DapaATcc Escherichia coli 21 □ D  R R L V D G M s S W w A Otsukact al. (1988)
Concensus G D G t
1 partial sequence ends at A54
* denotes Q52 DGD aligned with I, L, Y or W of subgroup II aminotransferases
--j
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Table S. Tyr30I to Pro400 DGD compared to PLP aminotransferases subgroup II.
Enzyme Source 1 I
DGD Burkholderia cepecia
1
Y T T H V S D P L P
AcomATag Alnus glutinosa G T T F A G G P L V
AcomATec Escherichia coli G S T Y G G N P L A
AcomATkl Kluyveromyces lactis G T T Y G G N P L G
AcomATs Synechocystis PCC6803 A S T F G G N P L A
AcomATy yeast G T T Y G G N P L A
AGATm mouse F S T F G G S P L A
ATbf Bacillus firmus G T T F G G N P I A
ATce Caenorhabdiiis elegans N - T Y G G N P L A
GabaATan Aspergillus nidulans F N T W M G D P S R
GabaATmt Mycobacterium tuberculosis G G T F G G N P V A
GabaATy yeast F N T W C G E P A R
omega-APATpp Pseudomonas putida G Y T Y S A H P V A
OmAThu human G S T Y G G N P L G
OmATm mouse G S T Y G G N P L G
DapaATbs Bacillus sphaericus S H S Y T G N T L A
DapaATec Escherichia coli G P [ _ □ F M G N L A
Concensus * T s G P
denotes Y301 DGD aligned with mostly G o f subgroup II aminotransferases 
5 denotes H304 DGD aligned with F, VV or Y o f subgroup II aminotransferases
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(omega-AP AT), tyrosine (OmAT) and tryptophan (DapaAT) of other subgroup II 
enzymes. All residues, except tyrosine, cannot hydrogen bond with respective substrates.
Investigations into the role o f  histidines in DGD. Using the Omiga 1.0.1. multiple 
sequence alignment function, the residues o f subgroup II members at positions 
corresponding to the seven histidyl residues o f DGD were tabulated in Table 9. Only 
some histidines within subgroup II are conserved. His 16, 139 and 294 DGD share no 
significant homology at corresponding positions o f  subgroup II members; in fact, the 
amino acids seem random. His59 is found in all except GabaATs and DapaATec. His61 
is present in some AcomATs, AGATm, a few OmAT, DapaATec but not in GabaAT, 
omega-APATpp and DapaATbs. All AcomATs and AGATm have histidyl residues at 
positions corresponding to DGD His77. In fact, His59, 61 and 77 are the most highly 
conserved histidines among the members. These histidines form either part o f  the DGD 
active site or maintain monomer-monomer interaction. The singular presence o f  His304 
in DGD is a surprise; other enzymes have bulky groups such as tryptophan, 
phenylalanine and tyrosine at corresponding positions. O f the three amino acids, only 
tyrosine is capable of donating a hydrogen bond.
The absence of His304 DGD at corresponding positions among other subgroup II 
members is intriguing and hence warrants further analysis. Table 8 shows alignment of 
Tyr301 to Pro400 DGD with other subgroup II enzymes. Threonine is conserved in all 
but one enzyme. Thr303 has important structural and functional implications in DGD 
catalysis (Toney et al., 1995a). It hydrogen bonds with potassium ion near the active site
77
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Table 9. Alignment o f  DGD histidines with PLP aminotransferases subgroup II.
Enzyme Source
16 59
Position in DGD 
61 77 139 294 304
DGD Burkholderia cepecia H H H H H H H
AcomATag Alnus glutinosa R H D H Q 1 F
AcomATec Escherichia coli E H H H p H Y
AcomATkl Kluyveromyces lactis Y H N H p L Y
AcomATs Synechocystis PCC6803 T H H H L P F
Acorn ATy yeast F H N H P L Y
AGATm mouse P H H H s A F
ATbf Bacillus firmus P H H G H W F
ATce Caenorhabditis elegans K H H H S N Y
GabaATan Aspergillus nidulans E Y N I T P W
GabaATmt Mycobacterium tuberculosis A N S T H H F
GabaATy yeast E Y N V S P W
omega-APATpp Pseudomonas putida Y H R S A M Y
OmAThu human Y H H L K I Y
OmATm mouse Y H H L K I Y
DapaATbs Bacillus sphaericus S H N T T Y Y
DapaATec Escherichia coli T Y H V E S F
Number of histidines I 13 9 8 3 3 1
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and also N-pyridines o f His77 and His304. Furthermore, the amide bond and hydroxyl 
groups of Thr303 donate hydrogen bonds to the oxygen atoms of the PLP phosphate 
ester. However, the threonine in other members cannot hydrogen bond to residues such as 
phenylalanine and tryptophan at positions corresponding to His77 DGD. Thr303 DGD, 
Thr322 OmAT and the structural equivalents in other enzyme members are indispensable 
for providing additional hydrogen bonds to phosphate oxygens of the cofactor. However, 
one cannot speculate the role of threonine in coordinating metal ions in other subgroup II 
members. OmAT, the only other subgroup II member o f known structure, shows no 
metal ions dependency (Shen et al., 1998); the structurally equivalent residue is 
positioned unfavorably to form ligands to a potassium ion. Metal ions requirement of 
other subgroup members has been somewhat studied. Echetebu et al. (1987) that found 
tyrosine aminotransferase is inhibited by metal ions Ca2~, Mn2+, Zn2+, Hg2+ and Ag2^ , but 
was unaffected by chelating agents and other divalent cations. The 3D structure of 
tyrosine aminotransferase is presently unavailable. Mayer et al. (1994) reported that 
glutamate-1-semialdehyde aminotransferase exhibits no metal ion dependency for 
activity. No discussion on such topic was provided in the 3D structure o f glutamate-1- 
semialdehyde aminotransferase published by Hening et al. (1997).
In addition to Gln52, Tyr301 has been speculated to be involved in DGD 
decarboxylation (Toney et al., 1995a). Residues at equivalent positions with Tyr301 
DGD are mostly glycines and phenylalanines (Table 8). The hydroxyl group of Tyr301 
has been postulated to hydrogen bond with Gln52.
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DGD and AAT active sites visualization with Sybyl 6.2. Sequence comparison analysis 
gives only a one dimensional view o f the functionality o f select residues. DGD and AAT 
active sites visualized with Sybyl molecular modeling software offer an added advantage 
to our analysis (Fig. 25A and B). Val39 AAT from E. coli (Okamoto et al., 1994) aligns 
with Gln52 DGD (Table 6) and is part o f a region known to undergo significant main- 
chain conformational change upon substrate analog binding. Segment movement shields 
the active site from the solvent environment. This is followed by protein backbone N 
atom of Gly38 hydrogen bonding to substrate a-carboxylate. Gln52 o f  DGD and Val39 
of AAT differ in their spatial orientation within the active site despite their alignment in 
the primary sequences. Gln52 amide side chain is positioned towards, and thus hydrogen 
bonded to substrate a-carboxylate (Figure 25A). Conversely, Val39 side chain faces 
away from the substrate (Figure 25B). It is evident that protein backbone twisting dictates 
the orientation of these residues. Hence, the ability o f an amino acid hydrogen bonding 
with substrate cannot be determined solely by primary sequence alignment.
In an attempt to convert AAT into an enzyme capable of catalyzing 
decarboxylation, V39 and a-CH 3 were replaced with glutamine and a-carboxylate 
respectively. Following energy minimization, the mutated residue glutamine was at 
relatively similar position as before; the amide side chain was still directed away from the 
active site. It is concluded that mutation Val39 to Gln39 is unlikely to adapt AAT into a 
decarboxylating enzyme.
80
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Figure 25 A. DGD active site residues. Gln52 hydrogen bonds to OS1 o f MES sulfonate group.
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Figure 25 B. AAT active site residues. Gly38 main chain N hydrogen bonds with a-carboxyl 
group o f  substrate. AAT x-ray crystal structure reveals that a rotation o f  helix brings the 
Gly38 nitrogen into a position to hydrogen bond with a-carboxyl o f the substrate, 2-methyl- 
L-aspartate (Okamoto et al., 1994).
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3.5. Discussion
DGD shares similar protein structure with OmAT and GabaAT, members of 
subgroup II aminotransferases (Toney et al., 1995b). While overall protein scaffolding 
among the enzymes may be similar, substrate specificity is not. The ability o f DGD to 
decarboxylate and transaminate at one active site probably arises from strategic residue 
alteration within that locality. Attempts to locate decarboxylases sharing sequence 
similarity with DGD amino end proved unsuccessful. DGD is more homologous to 
aminotransferases, despite its ability to catalyze decarboxylation. Additionally, DGD 
fulfills all the requirements as an aminotransferase outlined by Mehta et al. (1993).
Comparison o f active site amino acid composition of other subgroup II 
aminotransferases with DGD may aid in the dissection o f how specific amino acids 
contribute to DGD decarboxylation. DGD and OmAT are the only two subgroup II 
enzymes of known 3D structures (Toney et al., 1995a; Shen et al., 1998). Watanabe et al. 
(1989) gave a brief structural description of omega-AP AT. An active site model for 
GabaAT, based on DGD structure, was presented by Toney et al. (1995b).
Protein sequence comparison o f  Gln52 DGD to aminotransferase subgroup I  and II. It is 
hypothesized that Gln52 DGD enhances decarboxylation via formation of hydrogen bond 
to substrate carboxyl group (Toney et al, 1995a). Primary sequence comparison 
concluded that this hydrogen bonding feature is not shared among most subgroup I and II 
enzymes (except OmAT). Although the possibility o f the main polypeptide chain 
hydrogen bonding to substrate cannot be ruled out, bulky residues such as isoleucine,
83
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leucine and tryptophan prevent such bonding unless the side chains are positioned away 
from the active sites. Ultimately, hydrogen bonding to substrate carboxyl cannot 
guarantee decarboxylation as evident by analysis o f OmAT active site residues as 
described below. More importantly, the scissile bond must be perpendicular to the PLP 7t 
system for effective decarboxylation. Shah et al. (1997) presented the crystalline structure 
o f human OmAT complexed with inhibitors L-canaline and gabaculine. Tyr85 OmAT. 
which aligned with Gln52 DGD, does not hydrogen bond to analog carboxyl group. 
Instead, this residue contributes to die stability o f inhibitor-enzyme complex via ring to 
ring interaction that permanently inactivates the enzyme (Shah et al., 1997). Tyr55 and 
A rgl80 hydrogen bond to analog carboxyl in order to position ornithine for 
transamination at 5 position; alteration of these residues results in unproductive substrate 
turnover. In fact, these two specific tyrosine and arginine residues are present in all 
AcomATs, OmATs as well as DGD at similar location by alignment with Omiga 1.0.1. 
and slight manual adjustments. OmAT active site accommodates an elongated substrate 
that is absent in DGD probably explains why Tyr20 and Argl53 DGD are distant from 
the MES molecule and do not take part in catalysis.
Role o f  histidines in DGD. Sato et al. (1978) demonstrated chemical labeling of one of 
the seven histidyl residue converted DGD into an aminotransferase and suggested a 
modified histidine may participate in decarboxylation. Only three out o f  the seven 
histidines are located near the active site. His77 and His304 are near the potassium ion 
binding site. At present, the absolute requirement for potassium ions is unknown for
84
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DGD transamination or decarboxylation or both reactions. However, due to the close 
proximity o f the potassium ion o f a monomer to Gln52 (which was shown to promote 
decarboxylation) o f the other monomer, it is reasonable to propose that potassium ion, 
His77 and 304 are required for decarboxylation (Figure 26). To test the hypothesis, site 
directed His77 and 304 mutants o f wild type DGD, glutamine 52 —> histidine mutant 
(catalyzing decarboxylation only) and glutamine 52 —> glutamate mutant (catalyzing 
transamination only) could provide clues to the puzzle.
His 139, Asp243 and pyridine nitrogen o f PLP (Figure 27) could be as important 
to DGD as the equivalent trio is to the mechanism o f AAT (Yano et al., 1993) and most 
likely in GabaAT (Table 9). In AAT, the histidine-aspartate-N(l) o f  PLP trio forms a 
charge relay system that assists the electron flow from the labile bond towards the 
pyridine ring. Out o f the fifteen sequences analyzed, His59, 61 and 77 DGD are the most 
conserved histidines among the members. Coincidentally, these residues lie in regions 
either bordering the active site or participating in dimer formation.
Histidines have been shown to be important in coordinating metal ions in some 
enzymes. DGD has been shown to be dependent on potassium ions for activity and 
stability (Aaslestad et al., 1968). Wragg et al. (1997) demonstrated by selectively labeling 
histidines o f ppGaNTase with DEPC possibly inactivate the enzyme by interfering with 
the manganese binding site. Similarly, two strictly conserved histidines in 2-oxoglutarate- 
dependent dioxygenases and related enzymes are part o f  the putative iron-binding site 
(Lukacin and Britsch, 1997). The absolute conservation o f threonine in DGD (at position
85
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Figure 26. The positions o f  H is77 and H is304 relative to DGD active site. In this diagram . 
PLP and VIES reside at the active site o f  the other m onom er.
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Figure 27. The position o f  His 139 relative to the DGD active site (where PLP and MES are 
located).
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303) and associated enzyme members prompts the suggestion that the activities of some, 
if  not most, subgroup II enzymes are dependent on metal ions.
Comparison o f  DGD and AAT active sites. Primary sequences comparison aligned Gln52 
DGD with Val39. Gln52 DGD faces towards substrate while Val39 AAT faces away 
from substrates. A differential twist o f  the respective enzyme protein backbone determine 
whether the aligned residue can hydrogen bond with the substrate. Three o f the four 
invariant residues conserved in all aminotransferases (Mehta et al., 1993) are found in the 
2D representations o f DGD and AAT active sites (Figure 28). Lysines o f  both enzymes 
are positioned on the si face for proton abstraction. Asp243 DGD and Asp222 AAT 
stabilize the protonated N (l) o f  PLP via salt bridge formation. It accelerates the 
abstraction of a-group from the amino acid substrate and stabilizes the transition state 
(Yano et al., 1993). Equivalent aspartate residues are also found in crystal structures of 
tryptophanase (Isupov et al., 1998) and OmAT (Shen et al., 1998). Arg406 DGD, Arg292 
and Arg386 AAT provide positive charge to form ionic bond with substrate carboxyl 
group. This conserved feature is also shared among other enzymes catalyzing reactions 
involving mono/dicarboxylic acids as substrates. Examples include serine 
hydroxymethyltransferase (SHMT; EC 2.1.2.1), a PLP dependent enzyme catalyzing Ca- 
Cp cleavage (Jagath et al., 1997), and flavanone 3P-hydroxylase (EC 1.14.11.9), a non­
heme iron enzyme involved in the biosynthesis o f flavanols, anthocyanidins and 
catechins in plants (Lukacin and Britsch, 1997).
88
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Figure 28. 2D representation o f  Burkholderia cepacia DGD and Escherichia coli AAT active 
site residues. Top: Burkholderia cepacia DGD active site residues and 2MA/PLP substrate 
complex (Toney et al., 1995a). Bottom: Escherichia coli AAT closed form active site residues 
and L-aspartate/PLP complex (Okamoto et al., 1994).
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3.6. Conclusion
Further evidence was provided to show that DGD is an aminotransferase that has 
acquired decarboxylation activity through evolution. The four invariant residues in all 
PLP aminotransferases proposed by Mehta et al. (1993) were determined in DGD. The 
N-terminal protein sequence is more homologous to that o f aminotransferases even 
though GIn52 and hence the N-terminus were postulated to promote decarboxylation.
If DGD is more related to aminotransferases, how does it catalyze 
decarboxylation? Gln52 and one of the histidines at the active site have been suggested to 
enhance DGD decarboxylation activity. The potential of GIn52 DGD to form hydrogen 
bond with substrate carboxyl is an exception among the aminotransferases. However, the 
histidine that could be responsible for decarboxylation is less obvious; His77 and 304 that 
form part o f network that coordinates the potassium ion are likely candidates since the 
metal ion requirement in DGD transamination or decarboxylation or both reactions has 
yet to be determined.
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Chapter 4 
Protein purification and spectrophotometric studies of wild-type 2,2- 
dialkylglycine decarboxylase and the Lysine 272 to Alanine mutant
4.1. Abstract
The active site Lysine 272 to Alanine mutant of 2,2-dialkylglycine decarboxylase 
(DGD) was used to determine the catalytic function o f the residue during decarboxylation 
and transamination. The mutation seriously compromised the mutant’s ability to catalyze 
both decarboxylation and transamination reactions. The decarboxylation rate was 6.9 x 
10"3 that of wild-type while the transamination rate was undetectable. The results also 
indicated that Lys272 is important in catalyzing a-proton abstraction in L-ala, but not the 
departure of the carboxyl group in 2MA. However, effective and efficient catalysis of 
both substrates requires the transaldimination reaction that transfers the cofactor from 
Lys272 to substrate in order to ‘activate’ the substrate.
Wild-type DGD forms an absorption peak at 500 nm in the presence o f  3% 
glycerol. Accumulation of the quinonoid intermediate could be attributed to the decreased 
rate o f 4 ’-C protonation compared to the Ca-COO' and Ca-H bond cleavages. A more 
hydrophobic environment could affect the rate o f protonation at the substrate level. 
Different active site residues maybe involved in decarboxylation/deprotonation and
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protonation o f the PLP-substrate complex. Due to insignificant level o f  enzyme activity. 
K272A DGD does not form such an absorption peak.
4.2. Introduction
Lys272 has been shown to be indispensable in catalyzing the a-proton abstraction 
step in aspartate aminotransferase (Toney and Kirsh, 1989), D-amino acid 
aminotransferase (Nishimura et al., 1991), glutamate-1-semialdehyde (Grimm et al.,
1992) and tryptophan synthase (Lu et al., 1993). A lysine-to-alanine active site mutant of 
DGD was genetically engineered to allow investigation into the catalytic role o f Lys272 
(Brayman, 1993). Replacement o f active site lysine residue to alanine proved disastrous 
to enzyme activity. Brayman’s results showed that the mutant was unable to catalyze 
decarboxylation and transamination. He then concluded that Lys272 is critical in both 
half reactions. The active site lysine acts as general acid during decarboxylation and as 
general base during transamination. Attempts to restore catalytic activity of the mutant 
using exogenous amines to mimic the lost lysine side chain were unsuccessful (Brayman,
1993). Based on the results, Keller et al. (1997) suggested that the DGD active site 
environment is more hydrophobic than most aminotransferases since it precludes buffer 
and solvent molecules. It was later discovered that K123N mutation was unintentionally 
introduced during the construction of the expression vector o f K272A DGD. The 
mutation was excised and a gene region containing the correct codon was inserted (J. W. 
Keller, personal communication). Although mutation K123N is located on the protein
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surface and is unlikely to take part in catalyzing any reactions, K272A DGD activity was 
re-examined and the results compared to the K.123N, K272A double mutant.
Addition information on WT DGD protein purification was presented in this 
chapter. Several spectrophotometric studies on WT and BC272A DGDs were conducted. In 
particular, it was demonstrated that the K272A mutation has a more significant effect on 
transamination compared to decarboxylation.
4.3. Materials and Method
4.3.1. WT and K272A DGDs protein purification
DGD purification protocol has been outlined in Chapter 2. Briefly, the 
purification procedure entails sonication, ammonium sulfate precipitation, DEAE ion 
exchange chromatography and finally P-6DG gel filtration. Purified proteins were stored 
as 50% glycerol stock at -70°C.
4.3.2. WT and K272A DGDs spectrophotometric studies
WT and K272A DGDs holoenzyme preparations. Holoenzyme was prepared as follows. 
One hundred and eighty pg of purified protein (in 50% glycerol) was incubated with 50 
mM 2MA, 5 mM NaPyr and 50 pM PLP in a 50 mM phosphate buffer, pH 7.5 at room 
temperature for 10 min. The 50 pL solution was then loaded on CHROMA SPIN-10 
columns (Clontech) to remove unbound PLP, products and unreacted substrates.
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Reagents. Reaction rates were determined by monitoring the disappearance of pyruvate at 
220 nm over time. The ideal substrate concentration range is between 0.5 and 5 of 
substrate. This places 2MA and pyr concentrations in the range of 5 to 50 mM and 0.2 to 
2 mM respectively. Stock solutions included 62.5 mM phosphate buffer, pH 7.5, 1 mM 
PLP, 1000 mM 2MA and 40 mM sodium pyruvate. 2MA solution series were prepared to 
final concentrations o f 5, 10, 20 and 50 mM when delivered in 150 pL aliquots. Pyruvate 
solution series were prepared to give 0.2, 0.4, 1 and 2 mM final concentrations when 
delivered in 20 pL aliquots.
Assay protocol. In a 0.5 cm path length quartz cuvet, incubate the following reagents for 
5 min at 22°C: 800 pL phosphate buffer, 25 pL PLP and 10 pg protein. The Hewlett 
Packard 8452A diode array spectrophotometer was then rezeroed from 200 to 400 nm.
150 pL 2MA and 20 pL NaPyr were mixed throughly and then added to the cuvet. The 
decrease in pyruvate concentration was monitored by continuously scanning at 222 nm at 
every sec for 3 min. In a final reaction volume o f  1 mL, the enzyme concentration was 
measured at 0.1 mg/mL. Sixteen reactions were carried out at 22°C in a single 
experiment.
pH  dependence o f  molar absorptivity o fW T  and K272A DGDs. The pH dependence of 
the enzymes was investigated according to protocol similar to Brayman (1993). The 
spectra of WT and K272A DGDs were taken in the range o f 300 to 500 nm over a pH
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range from 5.5 to 11.0 in increments o f 0.5 22°C. The following buffers at 100 mM were 
used: 2-(N-morpholino) ethanesulfonic acid (MES), pH 5.5, 6.0, 6.5; morpholinopropane- 
sulfonic acid (MOPS), pH 7.0; N-(2-hydroxyethyl)piperazine-N’-2-ethanesulfonic acid 
(HEPES), pH 7.5; triethanolamine (TEA), pH 8.0; N-tris(hydroxymethyl)methyl-3- 
aminopropanesulfonic acid (TAPS), pH 8.5; 2-(N-cyclohexylamino)ethanesulfonic acid 
(CHES), pH 9.0, 9.5; 3-(cyclohexylamino)-propanesulfonic acid (CAPS), pH 10.0, 10.5 
and 11.0. Buffer pH was adjusted with 4 M NaOH or HC1. 2.5 pM WT protein in 300 pL 
buffer and 5.5 pM K272A in 500 pL buffer were added in quartz spectrophotometer 
cuvets and the spectra recorded. A ratio increase or decrease within the pH range could 
indicate enzyme active site is pH dependent.
K272A DGD decarboxylation and transamination ha lf reactions. K272A holoenzyme 
was prepared accordingly and tested for its ability to decarboxylate 2MA or transaminate 
L-ala. The reaction consisted o f 2.75 pM protein, 40 mM 2MA/L-ala in 15 mM 
phosphate buffer, pH 6.75 at 22°C.
4.4. Results
4.4.1. WT and K272A DGDs protein purification
Samples from each WT DGD purification step were run on a SDS-PAGE minigel 
(Figure 29). The purified enzyme was homogeneous as judged by the presence o f  a single
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45 kDa protein band corresponding to the DGD monomer. DGD percentages relative to 
total protein in each purification step were tabulated in Table 10. DGD purity is generally 
between 85 and 90%. Table 11 showed the total protein yield and specific activity of WT 
DGD at each purification stage. One hundred and forty units o f WT DGD were purified 
from approximately 40 g of bacterial pellet; specific activity (U/mg) of WT DGD 
increased 18-fold after the DEAE step.
4.4.2. WT and K272A DGDs spectrophotometric studies
WT DGD rate profile. The K2MA and were determined at 9.47±1.47 mM and 
0.52±0.06 mM respectively from the double reciprocal plot o f  pyruvate consumption rate 
versus concentration of 2MA (Figure 30).
Formation o f  WT DGD quinonoid intermediate. The sharp isobestic point between the 
330 nm and 400 nm peaks at 350 nm is consistent with the transformation o f  one PLP 
complex species into the PMP form (Figure 31). Presence o f glycerol in WT DGD 
reactions induced the formation of a chromophore absorbing maximally at 500 nm with a 
shoulder at 530 nm (Figure 32). The chromophore is generally attributed to the 
accumulation of quinonoid intermediates. A decrease in the PLP peak, an increase in the 
‘red’ peak and a somewhat constant PMP peak were observed. The peak is associated 
with the enzyme, as evident by the filtrate from protein concentration using Amicon® 
Centricon-30 (30,000 NW cut-off) showed no peak at 500 nm.
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Fig. 29. Densitometric analysis o f  a SDS-PAGE gel containing purified WT DGD. 20 pg 
protein in sonication and 5 pg protein in other samples were loaded and separated on 12% 
SDS-PAGE gel. Lane 1, MW markersa; lane 2, sonication; lane 3, A.S. pption; lane 4, 
dialysate; lane 5, pooled DEAE (highest protein conc.), lane 6, pooled DEAE 2 (high protein 
conc.). lane 7, pooled P-6DG (from lane 5). DGD band in a typical P-6DG sample scan would 
be 80 to 90% pure.
4 Novex Markl2™  wide-range protein standards: P-galactosidase (116 kDa), phosphorylase b (97.4 kDa), bovine 
serum albumin (66.3 kDa), glutamic dehydrogenase (55.4 kDa), lactate dehydrogenase (36.5 kDa), carbonic 
anhydrase (31.0 kDa) trypsin inhibitor (21.5 kDa) and lysozymc (14.4 kDa).
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Table 10. Densitometric analysis o f purified WT DGD in SDS-PAGE minigel.
Purification step % o f  total
Sonication 10
Ammonium sulphate precipitate 20
DEAE 75
PDG6 85 -90
Densitometric measurements and data analysis were done with the IS-1000 
Digital Imaging System, software version 1.97, Alpha Innotech Corporation.
Table 11. Yield o f  WT DGD per purification step.
Purification step Total mg mg/ml U/mg Total U 1 % protein retained
Sonication 565 4.3 /* b 100
A.S. precipitation1 221 11.0 ,b b 50
Dialysate 229 6.4 0.3 59.6 53
DEAE_ld 34 2.6 5.1 176.4 8
P-6DG ld 26 2.2 5.4 140.6 6
' one unit o f  enzyme activity represents the amount o f  enzyme consuming 1 pmol o f  pyruvate in 
50 mM phosphate buffer, pH 7.9, 150 mM 2MA, 1 mM pyruvate and 25 pM PLP per minute at 
22°C
1 specific activities are too low to be measured accurately 
c A.S. = ammonium sulphate 
J protein pool o f  highest specific activity
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Figure 30. Double-reciprocal plot o f  the initial velocity o f  the reaction catalyzed 
by WT DGD. 2MA final concentrations were 5, 10, 20 and 50 mM. Pyruvate final 
concentrations were 0.2, 0.4, 1 and 2 mM. The data were based on 3 sets o f  16 
enzyme assays.
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Figure 31. Spectrophotometric changes in WT DGD after 2MA and pyr 
addition. 700 pg protein, 50 mM 2MA, 5 mM pyr and 80 pM PLP in 50 mM 
phosphate buffer, pH 7.5.
W TDGD
w aveleng th  ( n m )
Figure 32. Spectrophotometric changes in WT DGD (glycerol) after 2MA  
and pyr addition. 10 pM protein (50% glycerol stock), 50 mM 2MA, 5 mM 
pyr and 80 pM PLP in 50 mM phosphate buffer, pH 7.5. Final glycerol 
concentration was 4 %  v/v. Note the appearance o f  a 500 nm absorption 
peak.
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p H  dependence o f  molar absorptivity o f  WT and K272A DGDs. All spectra showed two 
peaks with X ^  of 326 and 400 nm, representing PLP and PMP form of the enzymes 
respectively. The PLP/PMP ratio o f both proteins remained constant in the range of pH 
tested (results not shown). The lack of pH dependence o f WT and K272A is consistent 
with Brayman (1993); the pEC, at the internal aldimine nitrogen did not change from pH 
5.5 to 11.0.
K272A DGD decarboxylation and transamination rates. 2MA decarboxylation and L-ala 
transamination reactions of K272A holoenzyme took place to differing extent (Figure 
33). The holoenzyme exhibited two peaks with X^  of 330 and 400 nm, representing the 
enolimine (PMP) and ketoenamine (PLP) forms o f the cofactor residing at the active site. 
Addition of substrates in both half reactions shifted from 400 to 416 nm. Beyond this 
step, FC272A DGD decarboxylates 2MA to some extent but does not catalyze L-ala 
transamination. An extended K272A decarboxylation reaction consisting of 5.5 pM 
K272A holoenzyme and 40 mM 2MA in a 15 mM phosphate buffer, pH 6.75, determined 
first order reaction rate at 5.5 x 10'5 s'1 (Figure 34). K272A decarboxylation rate is 6.9 x 
10-5 that of WT DGD.
4.5. Discussion
WT DGD rate profile. The K.2MA and o f purified Burkhodaria (Pseudomonas) cepacia
DGD were 9.47±1.47 mM and 0.52±0.06 mM respectively. These values are in close
101
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Figure 33. K272A DGD decarboxylation and transamination half reactions. K272A/2MA: spectra recorded 
at 0, 0.5, 1. 1.5, 2 and 3.5 hr after adding 2MA. K272A/L-ala: scans recorded at 0. 0.5. 1, 1.5 and 2 hr after 
adding L-ala. Reaction conditions: 2.75 pM protein and 40 mM 2MA/L-aIa in 15 mM phosphate buffer. pH 
6.75.
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Figure 34. K272A DGD 18 hrs decarboxylation half reaction profile. Reaction 
conditions: 5.5 pM K272A, 40 mM 2MA in 15 mM phosphate buffer, pH 6.75. Time 
required to reduce half o f  total PLP was 3.5 hrs.
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range with those obtained from Bailey and Dempsey (1967), Aaslestad et al. (1968) and 
Lamartiniere et al. (1971) (Table 12). The eukaryotic DGD from Fusarium solani shared 
many characteristics with bacterial DGD, in terms of structural organization, physical 
properties and substrate specificity (Esaki et al., 1994). The affinity towards 2MA is 
almost 3 times that o f the bacterial DGD. Reaction rates at 2 mM pyruvate were slower 
than expected. This finding collaborates with Honma and Shimomura (1973) who 
reported concentration higher than 2 mM pyruvate inhibits DGD activity.
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Table 12. K;ma and values o f  bacterial and eukaryotic DGDs.
Source K:MA(mM) K^t (mM) References
Pseudomonad Ps-1 8 2 Bailey and Dempsey (1967)
Pseudomonad sp. 4.5 2.5 Aaslestad et al. (1968)
B. cepacia 8.7 1.7 Lamartiniere et al. (1971)
F. solani 28 3 Esaki et al. (1994)
1 not determined. K^ , a-ketobutyrate = 0.3 mM.
Formation o fW T  DGD quinonoid intermediate. Bond cleavage of the external aldimine 
results in the transient formation o f an intermediate, which absorbs at approximately 500 
nm. The ascribed carbanionic species is usually referred to as the quinonoid intermediate 
(Jenkins, 1964; Morino and Snell, 1967). Many PLP-dependent enzymes exhibit similar 
bands with quasisubstrates or inhibitors.
Addition o f glycerol induces the formation of a transient species absorbing at 500 
nm in WT DGD. The accumulation o f the quinonoid intermediate indicates that the 4 ’-C
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
protonation is slower than the Ca-COO' and C0-H bond cleavage. The solvent 
environment could have decreased the rate o f protonation. Alternatively, the reaction at 
a -  and 4 ’-C may be catalyzed by two different active site residues. A comparable 
example where two active site residues catalyze one reaction came from the mutagenesis 
studies o f D-amino acid transaminase reported by Yoshimura et al. (1992), who showed 
that although exogenous amines could not substitute for Lysl45 to abstract a-proton, 
K145N mutant was capable of performing transamination to a certain extent. They argued 
that an amino acid common to WT and K.145N enzymes, e.g. Lys267, probably plays a 
role o f being a less efficient base in the mutant, most likely as an auxiliary catalyst. 
Similar, a DGD active site residue other than Lys272 acts as a general base to abstract 
proton and a residue yet to be determined is responsible for protonation at 4 ’-C (see pages 
62 to 64 for more discussion).
K272A DGD lacked the ‘500 nm ’ chromophore found in WT DGD in the 
presence o f 3% glycerol, probably due to insignificant level of decarboxylation or 
transamination. One possible interpretation could be the reprotonation of the transient 
species is faster than the rate of decarboxylation in active site lysine mutant. This 
scenario may be possible only if another residue, and not Lys272, functions as the proton 
donor in the 4 ’-C protonation step.
pH  dependence o f  molar absorptivity o fW T  and K272A DGDs. The lack o f spectral 
changes as pH varies from 5.5 to 11.0 in both WT and K272A DGDs indicates that there
104
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is no change in the pfC, at the internal aldimine nitrogen of PLP residing at the active sites 
(Brayman, 1993; this work). Spectral data obtained from WT and K303A aromatic L- 
amino acid decarboxylase (Nishino et al., 1997) showed similar observation; the two 
enzyme forms showed no apparent pH dependency. On the contrary, spectra of 
tryptophanase (Zakomirdina et al., 1989), aspartate aminotransferase (Inoue et al., 1991) 
and aromatic amino acid aminotransferase (Hayashi et al., 1993) change with pH due to 
protonation of PLP-lysine aldimine at the active site. It is likely that DGD active site 
environment resembles that o f decarboxylases more than those o f aminotransferases and 
tryptophanase. The decarboxylation process is thought to depend on the hydrophobic 
environment that removes the water molecules and ions that might otherwise stabilize the 
carboxylate moiety (Marlier and O ’Leary, 1986).
K272A DGD decarboxylation and transamination half reactions. The PLP molecule 
bound at the K272A active site is optically active as determined by the CD spectrum of 
the mutant (Brayman, 1993). Since Schiffs base formation is impossible, the cofactor is 
anchored in place via non-covalent bonds such as ionic interaction and hydrogen 
bonding.
Active site lysine to alanine mutation cripples the ability o f K272A DGD to 
transaminate L-ala. The inability o f K272A DGD to catalyze transamination is consistent 
with PLP enzymes involving Ca-H cleavage where replacement o f lysine residue with 
other amino acids resulted in drastic decrease in catalytic rate. Mutagenesis studies of
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aspartate aminotransferase (Toney and Kirsh, 1989) and D-amino acid aminotransferase 
(Nishimura et al., 1991) showed that the lysine-to-alanine mutants lacked any significant 
level o f transamination but partial restoration o f activity could be accomplished by using 
exogenous amines as auxiliary catalysts. Brayman (1993) reported that attempts to use 
exogenous amines to revive the catalytic ability o f K272A mutant were unsuccessful. The 
exogenous amines could only act as base to abstract a-proton in active site K272A 
mutant provided the amines can enter the active site. However, the speculated 
hydrophobic active site environment o f DGD may prevent the entry of such auxiliary 
catalysts.
K272A mutation affects 2MA decarboxylation to a lesser extent, which is in 
agreement with the conclusion o f  Nishino et al. (1997) who demonstrated that Lys303 of 
aromatic L-amino acid decarboxylase is not essential for the decarboxylation step. Since 
there is no amino group at the position 303 in the mutant, substrate forms external 
aldimine with PLP via dehydration. Product release must then proceed via hydrolysis.
A number o f inferences emerge from the study. Firstly, Lys272 is critical for the 
a-proton abstraction step found commonly in reactions catalyzed by aminotransferases. It 
is anticipated that e-amino group of lysine, when liberated upon substrate-PLP external 
aldimine formation, acts as a general base catalyst for Ca proton abstraction. However, 
the decarboxylation step is not dependent on this lysyl residue since the mutant can 
catalyze the reaction at a very slow rate. The marked decrease in decarboxylation rate 
could be explained: The active site lysine is indispensable for the increase o f the
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reactivity o f  4 ’-aldehyde group of PLP by forming the Schiff base. Although the non- 
covalent bound PLP could form external aldimine with substrates and thus, in theory, 
reaction would pioceed, the lack of enzyme activity in the mutants implies the importance 
o f transformation from internal to external aldimine in promoting reactions of substantial 
rates.
4.6. Conclusion
In summary, Lys272 is important in catalyzing the a-proton abstraction in L-ala 
transamination and is not required for 2MA decarboxylation. The K272A DGD 
mutagenesis study is consistent with the current opinion that transamination involves 
Ca-H bond cleavage and the general base catalyst Lys272, whereas decarboxylation 
requires only bond breaking at Ca-COO\ However, Lys272 is necessary to 'activate' the 
substrate/PLP complex so that both decarboxylation and transamination reactions could 
be catalyzed at reasonable rates.
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Chapter 5 
Recommendations for future research
Recommendation 1: Combine chemical modification by DEPC and site-directed 
mutagenesis to elucidate the function o f  histidines in DGD.
This method was employed by Wragg et al. (1997). The role of histidine residues 
in ppGaNTase was evaluated by mutagenesis o f each hisitidine to an alanine residue. 
They proposed that the critical residues could be important in either coordinating the 
manganese ion, an essential factor for activity or maintaining structural integrity. The 
method could be modified to determine which histidine residues in DGD are critical for 
decarboxylation or transamination or both. Time dependent inactivation o f  the wild-type 
DGD and the histidine to alanine constructs is initiated with the addition o f DEPC and 
terminated with L-histidine. The inactivated wild-type and mutant DGDs could be tested 
for decarboxylation and transamination activities. In theory, wild-type DGD will exhibit 
a gradual decrease in activity as DEPC inactivation duration progresses. The mutants 
with non-critical histidine mutated to alanine will also follow similar inactivation curves 
as the wild-type DGD. However, mutants with histidine residues critical to either reaction 
mutated to alanine residues will show negligible activity from the start o f  DEPC 
inactivation.
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The PLP moiety in DGD is distant from the potassium ion (Figure 25, page 81), 
thus excluding direct involvement o f the monovalent cation in catalysis. However, as 
pointed out by Isupov et al. (1998), the potassium ion in tryptophanase may maintain the 
relative position of certain domain or segment o f the enzyme for effective catalysis. 
Likewise, mutation of His77 and His 304 to alanine residues may disrupt decarboxylation 
and/or transamination.
Recommendation 2: Mutagenesis o fTyr30l to glycine and phenylalanine to elucidate the 
function ofTyr30I.
Residues at equivalent positions with Tyr301 DGD are mostly glycines and 
phenylalanines (Table 8, page 76 ). The dual functionality of this residue in DGD is 
unique among the aminotransferases. Firstly, the hydroxyl group of Tyr301 is postulated 
to hydrogen bond with Gln52, which has been shown to be critical for the 
decarboxylation step. Secondly, Tyr301 is thought to contribute to the hydrophobicity of 
the active site environment which enhances decarboxylation. The tyrosine to glycine 
mutant abolishes both functions while the phenylalanine mutant retains its hydrophobic 
character but no hydrogen bonding to Gln52.
Recommendation 3: Use rapid-scanning stopped-flow spectrophotometry in conjunction 
with circular dichroism to study coenzyme/analog spectra.
Using rapid-scanning stopped-flow spectrophotometry, Philip et al. (1997) 
reported that tyrosine phenol-lyase and tryptophanase form absorbance peaks at 500 nm
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when reacted with fluorine-substituted analogs. The electron-withdrawing property o f the 
fluorine could enhance or retard reaction rates o f intermediate formation in a normal 
catalytic cycle. Also, fluorinated analogs could potentially disrupt critical hydrogen 
bonding between enzyme and substrate. Combination o f WT, Q52H, Q52E DGDs and 
fluorinated analogs would be useful in interpreting the mechanism of the DGD catalytic 
cycle, especially the quinonoid formation in the three DGD forms.
Ben-Kasus et al. (1996) studied CD spectra o f tryptophanase and its mutants with 
quasisubstrates, which are competitive inhibitors o f the enzyme. They reasoned that the 
reorientation o f either a tryptophan or tyrosine residue near the active site is thought to 
induce CD peak formation at 290 nm (Ben-Kasus et al., 1996). Once the covalent bond is 
formed between PLP and substrate, the residue shifts to its new position. It would be 
interesting to see if  DGD exhibits this peak because Trpl38 is located within the active 
site.
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APPENDIX 1 
E. coli codon usage table
Codon usage database compiled from CUTG (Codon Usage Iabuiated from Cenbank) 
Source : Genbank release 102 (15 Aug 97)
Fields : [amino acid] [triplet] [frequency per thousand]
Phe u u u 21.8 Ser UCU 9.1 Tyr UAU 16.2 Cys UGU 5.1
Phe u u c 16.7 Ser UCC 8.9 Tyr UAC 12.4 Cys UGC 6.4
Leu UUA 13.5 Ser UCA 7.6 Stop UAA 2.0 Stop UGA 1.0
Leu (JUG 13.2 Ser UCG 8.7 Stop UAG 0.3 Trp UGG 14.5
Leu c u u 11.1 Pro e c u 7.0 His CAU 12.7 Arg CGU 21.0
Leu c u e 10.7 Pro CCC 5.3 His CA C 9.8 Arg CGC 21.6
Leu CUA 3.9 Pro CCA 8.5 Gin CAA 14.7 Arg CGA 3.6
Leu CUG 52.0 Pro CCG 22.8 Gin CAG 29.0 Arg CGG 5.5
lie AUU 29.8 Thr ACU 9.4 Asn AAU 18.0 Ser AGU 8.8
He AUC 25.0 Thr ACC 23.1 Asn AAC 21.8 Ser AGC 15.7
lie AUA 4.8 Thr ACA 7.5 Lys AAA 34.3 Arg AGA 2.5
Met AUG 27.5 Thr ACG 14.0 Lys AAG 11.2 Arg AGG 1.5
Val GUU 18.9 Ala GCU 16.0 Asp GAU 32.1 Gly GGU 25.2
Val GUC 14.9 Ala GCC 25.3 Asp GAC 19.5 Gly GGC 29.2
Val GUA 11.2 Ala GCA 20.4 Glu GAA 39.8 Gly GGA 8.3
Val GUG 25.8 Ala GCG 32.9 Glu GAG 18.4 Gly GGG 11.0
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APPENDIX 2 
Correlation between codon usage with DGD production
DGD codon codon usage g o f cells mg DGD mg DGD/g o f  cells
WT Gtn CAG 29.0 13.2 51.0 3.86
Q52A Ala GCG 32.9 11.4 18.4 1.62
Q52D Asp GAT 32.1 12.0 45.5 3.79
Q52E Glu GAA 39.8 12.4 40.0 3.23
Q52G Gly GGC 29.2 18.0 23.8 1.32
Q52H His CAC 9.8 16.7 28.8 1.72
Q52K Lys AAG 11.2 9.0 19.8 2.20
Q52L Leu CTA 3.9 19.0 46.4 2.44
Q52N Asn AAT 18.0 8.2 16.8 2.04
Q52R Arg CGA 3.6 15.4 35.0 2.27
Q52W Trp TGG 14.5 16.2 15.6 0.96
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